国轩高科拟在欧洲投建年产18GWh生产基地

EQS 新闻 / 2022-06-29 / 09:22 UTC+8 国轩高科拟在欧洲投建年产18GWh生产基地 - 国轩高科的哥廷根基地预计分两期完成6GWh和12GWh,国轩电池开启“欧洲造”步伐 - 首款海外便携储能品牌GenDome亮相哥廷根基地,首款产品拟在哥廷根实现本地化生产 6月27日,国轩高科在德国哥廷根工厂举行了第五届新能源经济论坛暨德国国轩开幕仪式。据悉,哥廷根基地作为国轩在欧洲的首个电池生产运营基地,预计今年底启动改造。董事长李缜表示,国轩将中国先进的电池技术与德国先进的工艺工程完美地结合,正式开启国轩电池“欧洲造”步伐。当天的仪式上,国轩高科还发布了其首款面向海外市场的便携储能产品品牌GenDome及首款便携移动储能产品Gendock 3000。 中国驻德国特命全权大使吴恳,德国下萨克森州州长斯蒂芬‧魏尔,安徽省委常委、常务副省长刘惠、哥廷根市市长佩特拉‧布鲁伊斯特、合肥市人民政府市长罗云峰等中德政要与国轩高科董事长李缜共同参与并见证。 哥廷根基地首期6GWh预计今年底启动改造 据悉,哥廷根基地基地占地面积约17.4万平方米,现有建筑面积约4万平方米。根据规划,该项目分棕地工厂和绿地工厂两期建设,年产目标分别为6GWh和12GWh,其中第一期棕地工厂改造建设预计2022年底正式启动,2023年9月实现第一条产线3.5GWh的正式投产。基地棕地和绿地工厂完全投产后预计可实现年产18GWh的产能目标。 国轩哥廷根工厂厂长 Ahmet Toptas博士介绍:哥廷根基地会以产品为导向,以实现碳中和为终极目标,打造欧洲本土化的产品研发团队,结合欧洲新能源市场发展与技术导向,研发符合欧洲本土的新能源电池产品,开展大巴电池、汽车电池、储能电池、移动充电等系列产品的生产,未来客户拟覆盖储能、商用车及乘用车领域。“国轩高科先进的磷酸铁锂电芯技术,加上经验丰富的德国员工,严格的质量管控和欧洲高标准的品质要求,未来客户拟覆盖储能、商用车及乘用车领域,满足欧洲新能源市场的需求,助力国轩高科加速开拓海外市场。” 首款海外便携储能产品将在哥廷根本地化制造 继国轩高科5月份发布了半固态电池和首款智能移动储能充电桩之后,国轩高科的电池产品家族再添新成员。开幕仪式当天,哥廷根基地发布了首个面向海外市场的便携储能产品品牌GenDome,及其首款大容量便携移动储能产品Gendock 3000,可将太阳能和风能转化为电能;可帮助客户管理家庭能源使用,满足日常家庭和户外使用需求,能够满足客户99%的电力需求,有效减少能源支付账单。该款家用储能产品有三种不同型号,由国轩高科的国际业务团队研发及制造,未来主要面向欧洲市场,后期该产品将在哥廷根基地实现本地化制造。 开幕仪式当天,由国轩高科、百人会(Committee of 100)、布伦瑞克大学(Technical University of Braunschweig)、哥廷根经济促进与城市发展协会(GWG)和德国中国商会(Die Chinesische Handelskammer in Deutschland, CHKD)、同济大学汽车学院等联合举办的第五届新能源经济论坛也在哥廷根工厂顺利召开。论坛围绕中欧经济关系、能源革命、低碳化、新能源市场等话题进行讨论,吸引了新能源产业多家名企高管,大学教授学者及相关经济政要参加。 国轩高科董事长李缜: 中国技术加德国工艺,国轩电池开启“欧洲造” 国轩高科国际业务总裁李晨在闭幕致辞中介绍,国轩高科是一家全球化公司,为海内外供应商、客户等其他合作伙伴提供能源解决方案。“我们不仅聚焦新能源电池产品开发和推广,同步也致力于开拓TC业务。”李晨表示,2022年5月至今,国轩陆续发布国轩自主研发的首款面向普通消费者的易佳电智能移动储能充电桩产品和面向海外市场的Gendome便携储能产品。2025年国轩高科全球产能规划将达到300GWh,其中海外产能规划100GWh。 国轩高科董事长李缜在致辞中表示,今天我们在这里开启国轩电池在德国乃至欧洲的应用研发和产品制造。国轩的哥廷根工厂,将逐步从过去的生产汽车零部件,转变成制造电池应用产品,这是一个艰难但充满希望的历程。在此过程中一要保护好已有的企业文化,二要积极参与哥廷根的城市发展,三要加快产品转型的步伐。“我们一定将中国先进的电池技术,德国先进的工艺工程,完美地结合起来,创造更加美善的产品,贡献给社会,以推动新能源产业的进步与发展。” 文件: 国轩高科拟在欧洲投建年产18GWh生产基地 2022-06-29 此财经新闻稿由EQS Group转载。本公告内容由发行人全权负责。 原文链接: http://www.todayir.com/sc/index.php
More

博固泰®(特立帕肽注射液)上市申请 已经正式获中国国家药品监督管理局(NMPA)受理

EQS 新闻 / 2022-06-29 / 09:00 UTC+8 博固泰®(特立帕肽注射液)上市申请 已经正式获中国国家药品监督管理局(NMPA)受理 [2022年6月28日 – 香港]具备研发、生产及销售的一体化生物制药商——联康生物科技集团有限公司(「联康集团」或「本公司」,连同其附属公司统称「本集团」,股票代号:00690.HK)欣然宣布,本集团自主研发的博固泰®(特立帕肽注射液)递交的上市申请已于2022年6月28日获得中国国家药品监督管理局(「NMPA」)受理,受理号为“CXSS2200062国”。若本公司研发的博固泰®获得上市许可,将为患者提供更优的用药选择,是公司在骨科疾病领域的一项重大里程碑。 博固泰®(特立帕肽注射液)是集团继金因肽®、金因舒®、匹纳普®、博舒泰®之后上市的第五款产品,也是国内首款在一次性注射笔中推出PTH水针的国产品种。该产品是本公司与瑞士自我护理巨头Ypsomed合作开发的,拥有极细的注射针头和极高的剂量准确性,可极大减轻患者的注射痛苦。本集团坚信,博固泰®将能凭借其更强的成本优势,更好的治疗效果及便捷的给药方式,成为集团未来的重磅产品之一。 特立帕肽注射液采用生物表达技术,是一种重组人甲状旁腺激素类似物(PTH1-34),与84个氨基酸的人甲状旁腺激素的34位N末端氨基酸(生物活性区)具有相同的序列,用于治疗有骨折高发风险的绝经后妇女骨质疏松症,是国内外唯一批准上市的促骨形成类抗骨松药物,能够有效改善骨微结构、增加骨强度,同时能促进骨愈合,可显著降低绝经后妇女椎骨和非椎骨骨折风险。 我国是全世界骨质疏松人数最多的国家,根据2021年第七次人口普查的数据显示,目前我国60岁及以上人口为26402万,占比18.70%。流行病学调查显示:我国50岁以上人群骨质疏松症患病率女性为20.7%,男性为14.4%;60岁以上人群骨质疏松症患病率明显增高,并且女性尤为突出,高达51.6%。目前我国骨质疏松患者约为9000万人,骨质疏松市场规模约150-200亿元,目前特立帕肽占比仅为1%左右,较国外存在显著差距,主要在于价格昂贵且没有进入医保。但长期来看,随着我国人口老龄化加剧,医保体系覆盖的逐步健全和居民支付能力的提升,特立帕肽市场规模将明显加速增长。此外,博固泰®将凭借更高的成本效益、更安全有效的产品定位,契合目标患者人群的需求,较其他同类竞争对手比,也将确保更快的增长。 -完- 关于联康生物科技集团 联康生物科技集团有限公司主要从事药品研发、制造及分销之业务。集团研发中心备有整套系统,用于研发基因工程药品,并设有一个合乎国家药品监督管理局要求的中试车间和质量管控系统。集团亦分别于北京及深圳各设有一个符合最新药品生产质量管理规范(cGMP)的生产基地。同时,集团还拥有高效的商业化平台和营销网络。集团专注为糖尿病、骨质疏松等内分泌科、眼科及皮肤科研发创新的治疗药物。想了解更多详情,请访问联康集团官网:www.uni-bioscience.com。 如有相关咨询,请联络: 电子邮箱:ir@uni-bioscience.com 文件: 博固泰®(特立帕肽注射液)上市申请 已经正式获中国国家药品监督管理局(NMPA)受理 2022-06-29 此新闻稿由EQS Group转载。本公告内容由发行人全权负责。 原文链接: http://www.todayir.com/sc/index.php
More

嘉泓物流积极推动可持续发展 绿色物流服务成学术界研究案例

EQS 新闻 / 2022-06-29 / 08:30 UTC+8 嘉泓物流积极推动可持续发展 绿色物流服务成学术界研究案例 [香港-2022年6月29日] 国际知名的物流解决方案供应商 – 嘉泓物流国际控股有限公司(「嘉泓物流」或「本公司」,连同其附属公司,统称 「本集团」,股份代号:2130)一直重视可持续发展原则,致力将节能环保理念融入日常营运各环节,并在去年于港澳地区及内地推出一站式绿色物流服务,助力品牌客户加强资源再用及回收,并提供围绕碳排放咨询、碳足印追踪及中和的增值服务,与客户共同推广绿色供应链。期望满足客户对可持续发展的需求,同时运用自身影响力推动物流行业往绿色方向发展。 近日,本集团非常荣幸,协助香港工程师学会(物流及运输分组)王耀文博士及其团队(「研究团队」),包括香港都会大学建筑与品质管理系助理教授麦树麟博士及香港大学地理系名誉教授何建宗教授,进行对物流运输行业绿色解决方案的联合研究,而本集团的一站式绿色物流服务成为了当中的研究案例。研究团队将于今明两日(6月29日及30日)参加在北京举行的第三届绿色能源、环境与可持续发展国际学术会议,并在会议上向来自世界各地的学术界人士展示研究成果。 这次绿色物流服务得到学术界认可,是继早前获得《联合国气候变化纲要公约》证书和通过国际温室气体排放标准(ISO14064-3)认证,以及获得国际可持续发展评等机构EcoVadis给予铜级认证后,再次对本集团可持续发展工作的肯定。展望未来,本集团会从多方面实现节能减排,继早前在香港引入三部电动货车后,未来会在香港和内地扩充电动车队,继续推动绿色运输服务。集团亦计划在位适的海外仓房,安装太阳能电池板及雨水收集系统等,结合现有的绿色物流服务,期望本年度能减少6,000吨以上碳排放,并实现废物处理量超过30%增长,以进一步满足各界对可持续发展的需求。 嘉泓物流的执行董事兼首席执行官颜添荣先生表示:「几年前开始,我们便留意到品牌客户以至社会大众对可持续发展的关注日益提高,因此积极发展绿色物流,带领业界向低碳转型。我们非常高兴集团能成为学术界研究香港可持续物流发展的参考案例,向社界各界展示我们对可持续发展的理念和实践。未来我们会继续努力,推动不同的可持续发展计划,在日常营运节能减排,同时配合香港政府2050年前实现碳中和的发展蓝图,为未来、为下一代做出贡献。」 关于嘉泓物流国际控股有限公司 成立于1991年,嘉泓物流国际控股有限公司乃国际知名的物流解决方案供应商,核心业务为提供有关时尚产品及精品葡萄酒的空运代理服务以及配送及物流服务。根据灼识咨询报告,截至2019年12月31日止年度,本公司在中国及香港高端时尚产品的配送及物流市场中均排名第一。 2022-06-29 此财经新闻稿由EQS Group转载。本公告内容由发行人全权负责。 原文链接: http://www.todayir.com/sc/index.php
More
Milestone of THz Communication JCN Newswire

Milestone of THz Communication

TOKYO, Jun 29, 2022 - (JCN Newswire via SEAPRWire.com) - Scientists from a project coordinated by Technische Universitat Braunschweig in Germany and Waseda University in Japan with ten other partners from five countries have succeeded for the first time worldwide in developing a bidirectional THz radio link that can be connected as a "backhaul" to the data network of mobile radio providers. This link achieved by the Horizon Europe-funded new windowThoR project, can realise high data rates and thus play an important role in the network infrastructure of the future. On 29 and 30 June, the THz radio link will be presented in a final workshop of the ThoR project. The Braunschweig radio relay link connects the Oker Tower with TU Braunschweig's IT Centre over a distance of 160 metres. Credits: Thomas Kürner/ TU BraunschweigFibre-optic cables are not always the best option when it comes to transmitting data. Especially in cities, it is often not possible to connect every base station of the mobile network by cable. Radio relay links provide an alternative solution. With the help of antennas mounted on roofs, they can bridge distances of up to one kilometre. This creates important backhaul connections between mobile radio cells and the nodes of the mobile radio network without the need for any road construction work. Until now, the high data rates produced by the 5G mobile communications standard, which will continue to increase in the future 6G standard, favoured a fibre-optic connection between stations to the data networks. The international ThoR project has now succeeded in developing a bidirectional terahertz radio link that can reliably transmit these high data volumes. The frequency range above 300 gigahertz is used for this as it offers enough spectrum for high data rates. The ThoR-backhaul link is the only one of its kind in the world to offer a bidirectional real data connection and connects TU Braunschweig's IT centre with the Oker high-rise building over a distance of 160 metres. It can transmit data rates of 2x20 Gbit/s net at a bandwidth of 2x8.64 GHz and is scalable over the bandwidth so that higher data rates can also be realised. Professor Thomas Kurner, coordinator of the European part of the project: "We have realised an application-oriented complete solution here, which can already be used as a backhaul link in the data network in the near future." In addition, as the first backhaul link of its kind, its functionality also complies with the IEEE 802.15.3 standard. The IEEE 802.15.3 standard was already developed in the run-up to the ThoR project and substantial research contributions were made by TU Braunschweig and several of the Japan-based partners. On 29 and 30 June, the final workshop of the ThoR project will take place in hybrid form. In addition to attending the workshop in person in the Aula of the Haus der Wissenschaft (Pockelstrabetae 11, 38106 Braunschweig), it will also be possible to participate online. The core of the workshop is the demonstration of the backhaul track with a tour of the developed THz hardware. Registration for the workshop is possible new windowonline. The ThoR project is funded by the EU through the Horizon 2020 research framework programme (Grant Agreement 814523) and by the National Institute of Information and Communications Technology in Japan with a total of three million euros. The project started on 1 July 2018 and will end on 30 June 2022. Partners of the ThoR project:TU Braunschweig (EU coordinator, Germany), Waseda University (Japanese coordinator, Japan), Chiba Institute of Technology (Japan), Gifu University (Japan), University of Stuttgart (Germany), Fraunhofer Institute for Applied Solid State Physics IAF (Germany), University of Lille-CNRS IEMN&PhLAM Laboratories (France), HRCP R&D Partnership (Japan), Vivid Components Ltd (UK), Siklu Communication Ltd (Israel), NEC Corporation (Japan) and Deutsche Telekom (Germany/Czech Republic). Further information can be found at: https://thorproject.eu/About NEC CorporationNEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of "Orchestrating a brighter world." NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com. Copyright 2022 JCN Newswire. All rights reserved. (via SEAPRWire)
More
Indonesian calls, messages at G7 Summit ACN Newswire

Indonesian calls, messages at G7 Summit

JAKARTA, Jun 30, 2022 - (ACN Newswire via SEAPRWire.com) - Indonesian President Joko Widodo (Jokowi) has arrived at the venue of the 48th G7 Summit in Schloss Elmau, Germany on Monday afternoon (June 27) local time (UTC+1) to attend the meeting in the capacity of a partner country and as the G20 President.Indonesian President Joko Widodo in conversation with French President Emmanuel Macron and United States President Joe Biden while attending the G7 Summit in Elmau, Germany, Monday, June 27, 2022. ANTARA/HO-Press Bureau of the Presidential Secretariat/Laily Rachev/aa/ak. (Handout of Press Bureau of the Presidential Secretariat/Laily R)The G7 is an informal forum bringing together leaders of the world's leading industrial nations from the European Union and countries such as Canada, France, Germany, Italy, Japan, the United Kingdom, and the United States.Jokowi was welcomed by German Chancellor Olaf Scholz.During the official welcoming session by the chancellor, Jokowi was present with the leaders of G7 partner countries, including Argentine President Alberto Fernandez, Indian Prime Minister Narendra Modi, Senegalese President Macky Sall, and South African President Cyril Ramaphosa.Furthermore, during the photo session, he posed for a picture accompanied by the German chancellor and United States President Joe Biden.All heads of government attended two sessions of the G7 meeting.President Jokowi invited G7 countries to contribute to capitalizing on investment opportunities in the clean energy sector in Indonesia.President Jokowi conveyed the statement while attending the G7 Summit working lunch session based on the topics of climate change, energy, and health in Elmau, Germany, Monday (June 27)."(This is) especially (regarding) investment opportunities in the clean energy sector in Indonesia, including the development of an electric car and lithium battery ecosystem," the president stated.According to President Jokowi, Indonesia's potential, as a contributor to clean energy, whether in the bowels of the earth, on land, or at sea, is very large. Indonesia needs large investments and low-carbon technologies to support a fast and effective transition to clean energy."Indonesia needs at least US$25-30 billion for energy transition in the next eight years. We can optimize this transition as a motor of economic growth, open up business opportunities, and create new jobs," President Jokowi stated.Furthermore, the president noted that in Indonesia as well as in other developing countries, the risk of climate change is very real, especially since it is an archipelagic country, with 17 thousand islands. The risks are not only detrimental to health but also put farmers and fishermen in trouble."We really hope for the support of all G7 countries in the Indonesian Presidency at the G20. See you in Bali. Thank you," the president stated.During session II of the G7 summit on the topics of food security and gender equality, President Jokowi called on G7 and G20 countries to jointly overcome the food crisis that currently threatens people in developing countries to fall into extreme hunger and poverty."(Some) 323 million people in 2022, according to the World Food Programme, are at risk of facing acute food insecurity. The G7 and G20 have a big responsibility to overcome this food crisis. Let us fulfill our responsibilities now and from now on," President Jokowi affirmed.According to the president, food is the most basic human rights issue. Indubitably, women from poor families suffer the most from food shortages for their children and families."We must act quickly to find a concrete solution. Food production must be increased. The global food and fertilizer supply chain must return to normal," the president stated.In his speech, President Jokowi emphasized the importance of G7 countries' support for the reintegration of Ukraine's wheat exports and Russia's exports of food and fertilizer commodities in global supply chains.There are two ways to realize this, with the first being the facilitation of Ukraine's grain exports that can begin immediately.According to the president, the second approach is proactive communication with the public worldwide that food and fertilizer commodities from Russia are not subject to sanctions."This intensive communication is very necessary, so that there is no prolonged doubt in the (minds of the) international public. This intensive communication also needs to be strengthened with communication with related parties, such as banks, insurance, shipping, and others," the president explained.President Jokowi had paid significant attention to the impact of the war on food and fertilizer supply chains."(This is) especially for fertilizers, because if we fail to handle it, then a rice crisis involving two billion people, especially in developing countries, can occur," the president cautioned.At the end of his remarks, the president again called for the importance of the G7 and G20 countries to jointly overcome this food crisis while also inviting G7 leaders to attend the G20 Summit in Bali."I am waiting for the G7 leaders to attend the G20 summit. See you in Bali, on November 15-16, 2022," President Jokowi stated.Meanwhile, Minister of Foreign Affairs Retno Marsudi noted that the president held about nine bilateral meetings with: the Prime Minister of India; French President; Prime Minister of Canada; Chancellor of Germany; British Prime Minister; Prime Minister of Japan; President of the European Commission; President of the Council of Europe; and the Managing Director of the IMF.During the bilateral meetings, besides inviting other countries to solve the problems of the food supply chain, president Jokowi also highlighted the preparations for the G20 Summit."In these meetings, we can clearly see that support for the Indonesian Presidency is still very strong," Marsudi noted.In 2022, Germany takes over the G7 Presidency and hosts the 48th G7 summit held on June 26-28, 2022, in Schloss Elmau.The G7, originally G8, was set up in 1975.The annual G7 summits have, over the years, developed into a platform for determining the course of multilateral discourse and shaping political responses to global challenges.Written by: Azis Kurmala, Editor: Fardah Assegaf (c) ANTARA 2022 Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
Jacobson Pharma Announces FY2022 Annual Results ACN Newswire

Jacobson Pharma Announces FY2022 Annual Results

HONG KONG, Jun 29, 2022 - (ACN Newswire via SEAPRWire.com) - Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of essential medicines, specialty drugs and branded healthcare products, today announced the annual results of the Company and its subsidiaries (collectively the "Group") for the year ended 31 March 2022 ("FY2022" or the "Reporting Period").KEY HIGHLIGHTS-- Year-on-year revenue up by 10.3%, amounting to HK$1,595.5 million -- Profit for the year up by 78.4%*, amounting to HK$187.7 million-- Strong growth witnessed on key therapeutic classes for chronic diseases such as lipid lowering agents and angiotensin II inhibitors -- Progress with expansion plan in Greater China as facilitated by Greater Bay Area ("GBA") healthcare policy and formation of joint venture with an established partner-- Delivery of approximately 9 million doses of Fosun BioNTech Comirnaty Vaccine in Hong Kong and Macau for the collaborative fight against COVID-19 During the Reporting Period, the Group delivered total revenue of HK$1,595.5 million with a year-on-year growth of 10.3%, primarily driven by the solid growth momentum of business in the public sector. The profit from operations and profit for the year was registered at HK$260.9 million and HK$187.7 million, representing a promising growth of about 48.9%* and 78.4%* respectively, as compared to the adjusted profit from operations* and adjusted profit* for the corresponding year of 2021. The Group's financial position remains stable as supported by a healthy cash flow, with adjusted earnings before interest, taxes, depreciation and amortisation (adjusted EBITDA) posted at HK$441.6 million for the Reporting Period and a net gearing ratio at 29.2% as of 31 March 2022. With a cash balance of HK$478.7 million as of the end of the Reporting Period, the Group also recently secured a syndicated loan of HK$1.4 billion to enhance its capital capability. The Board has recommended the payment of a final dividend of HK2.68 cents per share (FY2021: HK1.50 cents per share). Excluding the FY2021 special interim dividend in the form of distribution in specie of shares of JBM (Healthcare) Limited (Stock code: 2161.HK), an indirectly non-wholly owned subsidiary of the Company, total dividend for the Reporting Period amounts to HK3.88 cents per share (FY2021: HK2.30 cents per share), an increase of 68.7%.Solid Performance of Generics BusinessThe Group's generic drugs business demonstrated a resilient performance amidst the COVID-19 pandemic, presenting a solid growth of 13.6%, with revenue posted at HK$1,191.3 million for the Reporting Period. The Group's product offerings in the key therapeutic classes for chronic diseases such as diabetes and cardiovascular disease achieved high double-digit growth. For instance, the lipid-lowering product class recorded a strong growth of 37.2% in sales during the Reporting Period. In addition, the oncology drug class has also shown a significant growth of 572.6%, owing to the increased acceptance of the new Arsenic Trioxide Oral Solution.As a major supplier of essential medicines in Hong Kong, the Group responded swiftly to cater to the surged demand for medications during the fifth wave of the epidemic. This was reflected by the strong growth in the Group's analgesics (+18.6%), cough & cold preparations (+45.8%) and anti-inflammatory products (+77.5%). Steady Pipeline and Portfolio EnhancementThe Group continued to make steady progress with its research and development ("R&D") pipeline. As of 31 March 2022, the Group has a total of 172 products in the pipeline, among which 54 items have been approved for registration, 15 of them have been submitted for registration, 52 items have finished the development stage and are under stability preparation or stability study, plus 25 items are currently under formulation or pre-formulation research development stage.As a continuous drive for portfolio enhancement, the Group launched a number of new products during the Reporting Period, including Rabeprazole Tablets, Valsartan and Amlodipine Tablets, Telmisartan and Hydrochlorothiazide Tablets, Pregabalin Capsules, Atosiban Injection, and Idarubicin Injection. Additionally, the Group has secured the registration approvals for a group of new products such as Levetiracetam Tablets, Febuxostat Tablet, Dexmedetomidine Infusion, Pramipexole Extended Released Tablets, Brimonidine and Timolol Eye Drops, Telmisartan and Amlodipine Tablets for upcoming market launches. Tapping Specialty Drugs Market in China and AsiaFacilitated by new measures under the "Work Plan for Regulatory Innovation and Development of Pharmaceutical and Medical Devices in the Guangdong-Hong Kong-Macau Greater Bay Area", the Group has established collaboration with the University of Hong Kong-Shenzhen Hospital for the introduction of its Arsenic Trioxide Oral Solution (indicated for the treatment of acute promyelocytic leukaemia) into designated hospitals in the Greater Bay Area. The collaboration will also be part of a multi-centre clinical trial covering Guangdong, Singapore and Hong Kong. More recently, the Group, together with its non-wholly owned subsidiary, JBM (Healthcare) Limited (Stock code: 2161.HK), formed a joint venture with Ban Loong Holdings Limited (Stock code: 0030.HK), a company of which Yunnan Baiyao Group Co., Ltd (Stock code: 0538.SZ) is the controlling shareholder, to capture the growth opportunities of the specialty medicines in Greater China and the Asia-Pacific region. The joint venture will be primarily engaged in exploring business opportunities in various growth streams including specialty medicines (including orphan drugs), over-the-counter drugs, and branded healthcare products as well as medical devices in the Greater China region.Distribution of Fosun BioNTech Comirnaty Vaccine in Hong Kong and MacauThe Group is the exclusive distributor of Fosun BioNTech Comirnaty Vaccine (the "Vaccine") in Hong Kong and Macau. Up to the end of the Reporting Period, the Group delivered approximately 9 million doses of the Vaccine to the Department of Health and community vaccination centres in Hong Kong and the Macau governments. To protect the public against COVID-19 and help ensure herd immunity through vaccination, the Group is committed to supporting the governments and professional partners in the acceleration of vaccination in Hong Kong and Macau, especially among the elderly, and will continue to collaborate with the Shanghai Fosun Pharmaceutical (Group) Co., Ltd. and its subsidiaries to supply booster vaccination doses for the public, as encouraged by the health authorities.Mr. Derek Sum, Chairman and Chief Executive Officer of Jacobson Pharma, concluded, "While the pandemic continues to impact the market environment, the Group delivered a solid performance in FY2022 by focusing on strong execution, bolstered by our core capabilities and enhanced product pipeline and portfolio. We also take pride in playing a collaborative role in the distribution of the Fosun BioNTech Comirnaty Vaccine in Hong Kong and Macau and have demonstrated our commitment to robust manufacturing and logistics operations by ensuring a continuous supply of our essential medicines were delivered to hospitals and patients during Hong Kong's fifth wave of the epidemic."Looking ahead, we are entering 2022 with positive momentum as we aim to build a differentiated portfolio that anticipates future healthcare needs. By executing our R&D and in-licensing strategies, fostering strong partnerships, and cementing our foothold in key strategic markets, we will further diversify and transform our business, bringing sustainable growth and value to shareholders."About Jacobson Pharma Corporation Limited (Stock Code: 2633)Jacobson Pharma is a leading pharmaceutical company in Hong Kong vertically integrated and engaged in the research, development, production, sale and distribution of essential medicines and specialty drugs. As a major provider of generic drugs in Hong Kong, the Group has one of the most extensive sales and distribution coverage for both the private and public sectors in Hong Kong, with an expanding reach into strategically selected Asian markets. Carrying a broad product portfolio and taking a pre-eminent market position in a number of therapeutic categories, the Group operates a host of 10 PIC/S GMP licensed production facilities for generic drugs in Hong Kong.The Group aims at the continued strategic enrichment of its generic drug portfolios through the addition of high-value-added products. With its corporate headquarters based in Hong Kong, the Group has also established its operating subsidiaries in China, Macau, Taiwan and Cambodia, forming a regional commercial platform to tap the market potential in the Asia Pacific and Greater China region. Jacobson Pharma has been a constituent stock of MSCI Hong Kong Micro Cap Index since 1 June 2017. For more details about Jacobson Pharma, please visit the Group's website: http://www.jacobsonpharma.com * Excluding the one-off Employment Support Scheme subsidy from the Hong Kong Government of about HK$81.1 million in FY2021 Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
Tat Hong Equipment Service Co., Ltd.  Announces FY2022 Annual Results ACN Newswire

Tat Hong Equipment Service Co., Ltd. Announces FY2022 Annual Results

HONG KONG, Jun 29, 2022 - (ACN Newswire via SEAPRWire.com) - Tat Hong Equipment Service Co., Ltd. ("Tat Hong" or the "Company", together with its subsidiaries, the "Group") (Stock Code: 2153), the first foreign-owned tower crane service provider established in the PRC, has announced its annual results for the year ended 31 March 2022 ("FY2022" or the "Year").In FY2022, the Group recorded revenue amounting to RMB867.0 million, representing a 9.3% increase from that for the year ended 31 March 2021, primarily due to the increase in the number of both self-owned and rented tower cranes, the majority of which had been working on-site and generating revenue. The Group's total Tonne Metres in use increased from approximately 2,491,629 in FY2021 to 3,112,084 in FY2022.Gross profit decreased by approximately 14.3% to RMB234.1 million for the Year. Profit for the year amounted to RMB47.6 million for the Year (FY2021: RMB101.2 million). The decrease was primarily due to the impact of accounting treatment (a non-cash adjustment) on the value of the shares awarded to the top management of the Company in March 2022 under the share award scheme contributed by the shares of the Company owned by the controlling shareholders of the Company. The Board of Directors recommended the payment of a final dividend of HK1.6 cents per share. As at 31 March 2022, the Group had 288 projects in progress with a total outstanding contract value of approximately RMB569 million and 42 projects on hand with a total expected contract value of approximately RMB102 million. Of these projects, the Group expects to complete contract work of approximately RMB497 million by the year ending 31 March 2023, demonstrating high and solid earnings visibility in the forthcoming year.Mr. Sean Yau, CEO of Tat Hong Equipment Service Co., Ltd. said, "FY2022 was a tough year not only to us, but to the entire market as well. Despite COVID-19 pandemic prevention and control measures, vaccination rates have begun to rise in various countries, and economies including China are gradually recovering. However, global public health, economy and employment are still adversely affected by it. With the continued occurrence of COVID-19 pandemic situation across the world, the global market is still facing many uncertainties under the pandemic. We will take this opportunity to expand new market opportunities and continue to provide customers with one-stop tower crane solution services."During the Year, the Group expanded its business by purchasing additional tower cranes and relevant ancillary parts and components to meet the increasing customers' demand. As at the date of this announcement, a total of 1,180 tower cranes were managed by the Group, equipped to cater for the Group's customers' specialised range of EPC projects throughout the PRC. As a well-recognised foreign-owned tower crane service provider in the PRC, the Group has also built a strong reputation in our awareness to workers' safety, service quality and technical strength. The Group currently possesses 77 registered patents for utility models and inventions relating to tower cranes.In addition to enhancing the manufacturing capability, the Group has continuously enhanced its remanufacturing and reprocessing capabilities for tower cranes and their ancillary structural components, as well as committed to providing a green service and to improving the operational and management efficiency through developing the digital management platform "iSmartCon".Looking ahead, we will focus on operation of medium and large size tower cranes to meet the growing needs for prefabricated construction, and to establish a standardized post market service eco-system for tower cranes so as to provide a green, safe and environmental friendly tower crane service foundation.Mr. Roland Ng, Chairman of Tat Hong Equipment Service Co., Ltd. concluded, "Going forward, the Group, with the effective execution of the PRC prevention and control policies, will continue to pay attention to the situation of the COVID-19 pandemic to ensure the safety of the employees and to mitigate its negative impact on the financial position and operating results. We will continue to consolidate our strengths and leading position in the market with a view to capture the huge market growth opportunities, driving sustainable long-term business and bringing satisfactory returns to our shareholders." Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
雅各臣公布二零二二财年全年业绩 ACN Newswire

雅各臣公布二零二二财年全年业绩

HONG KONG, Jun 29, 2022 - (亚太商讯 via SEAPRWire.com) - 从事基础药物、专科药物及品牌医疗保健品研发、生产、市场推广及销售的领先企业 ─ 雅各臣科研制药有限公司 (「 雅各臣 」或「 公司 」; 股份代号: 2633.HK )今天公布公司及其附属公司(统称「集团」)于截至二零二二年三月三十一日止年度(「二零二二财年」或「报告期」)的全年业绩。业绩亮点-- 收益按年增长10.3%至1,595.5百万港元-- 年内溢利增加78.4%*至187.7百万港元 -- 集团于其主要治疗类别业务取得强劲增长,例如降脂剂和血管紧张素II抑制剂等产品-- 大中华区扩展计划取得进展,受益于大湾区推出利好医疗保健政策,及与知名伙伴成立合资公司开拓市场-- 提供合共约9百万剂复星BioNTech复必泰疫苗给香港及澳门,共同抗击2019冠状病毒病疫情于报告期内,集团录得总收益1,595.5百万港元,按年增长10.3%,主要受公营界别业务稳健的增长势头推动。经营溢利及年内溢利则录得260.9百万港元及187.7百万港元,分别较二零二一年同期的经调整经营溢利*及经调整溢利*大幅增长48.9%*及78.4%*。集团财务状况维持稳健,现金流强劲。报告期录得扣除利息、税项、折旧及摊销前的经调整盈利(经调整EBITDA)441.6百万港元,截至二零二二年三月三十一日的净资本负债比率为29.2%。于报告期末,集团的现金余额为478.7百万港元,集团最近亦取得一笔14亿港元的银团贷款,有助进一步巩固资本实力。董事会建议宣派末期股息每股2.68港仙(二零二一年财年:每股1.50港仙)。不计及以实物分派形式分派公司间接非全资附属公司健倍苗苗(保健)有限公司(股份代号: 2161.HK ) 股份的二零二一年财年特别中期股息,报告期内的股息总额为每股3.88港仙(二零二一年财年:每股2.30港仙),较二零二一财年多派股息68.7%。 非专利药业务表现扎实报告期内,集团非专利药业务在疫情影响下仍然表现强韧,实现13.6%的稳健增长,收益为1,191.3百万港元。集团的产品于各个慢性疾病的主要治疗类别,包括糖尿病及心血管疾病等,均取得高双位数的增长。例如,降脂产品类别的销售于报告期内录得37.2%的增长。此外,由于公营界别对新药三氧化二砷口服液(Arsenic Trioxide Oral Solution)的接受性提高,肿瘤药物类别销售亦录得572.6%的大幅上升。 作为香港主要的基础药物供货商,集团迅速应对于第五波疫情期间激增的药物需求。镇痛剂(+18.6%)、咳嗽、感冒制剂(+45.8%)及抗炎产品(+77.5%)的强劲增长均反映相关药物的需求殷切。稳定加强产品管道及组合集团在持续推出新研发产品方面取得稳定进展。截至二零二二年三月三十一日,集团正在研发172项产品,其中54项已获准注册,15项已提交注册,52项已完成开发阶段并正进行稳定制备或稳定性研究,另有25项目前正进行配方研究或预制配方研究工作。为进一步丰富产品组合,集团于报告期内推出多项新产品,当中包括雷贝拉唑片(Rabeprazole Tablets) 、缬沙坦(Valsartan)及氨氯地平片(Amlodipine Tablets)、替米沙坦(Telmisartan)、及氢氯噻嗪片(Hydrochlorothiazide Tablets)、普瑞巴林胶囊(Pregabalin Capsules)、阿托西班注射剂(Atosiban Injection) 及埃达霉素注射剂(Idarubicin Injection)。此外,集团已就多项即将上市的新产品获得注册批准,例如左乙拉西坦片(Levetiracetam Tablets)、非布司他片(Febuxostat Tablet)、右美托咪定浸剂(Dexmedetomidine Infusion)、普拉克索缓释片剂(Pramipexole Extended Released Tablets)、酒石酸溴莫尼定及第莫洛滴眼液(Brimonidine and Timolol Eye Drops)、替米沙坦(Telmisartan)及氨氯地平片(Amlodipine Tablets)。拓展中国及亚洲专科药物市场在新推出的「粤港澳大湾区药品医疗器械监管创新发展工作方案」政策引导下,集团与香港大学深圳医院合作,计划将其用于治疗急性早幼粒细胞白血病的口服溶液-三氧化二砷口服液引入大湾区指定医院,这合作亦将作为覆盖广东、新加坡及香港的多中心临床试验的一部分。最近,集团连同其非全资附属公司健倍苗苗(保健)有限公司(股份代号:2161.HK)与万隆控股有限公司(股份代号:0030.HK),其控股股东为云南白药集团有限公司(证券代号0538.SZ),成立合资公司,以把握大中华区及亚太区专科药的增长机遇。该合资公司将主要在大中华区发掘专科药(包括罕见病用药)、非处方药、品牌医疗保健品及医疗器械的增长商机。在香港及澳门分销复星BioNTech复必泰疫苗集团为复星BioNTech 复必泰疫苗(「疫苗」)在香港及澳门的独家分销商。截至报告期末,集团已向香港的卫生署及小区疫苗接种中心及澳门政府提供合共约9百万剂疫苗。为了透过疫苗接种以对公众抵御2019冠状病毒病提供保护及实现群体免疫,集团致力与政府及专业伙伴合作,加快港澳地区特别是长者的疫苗接种率。在卫生部门的鼓励下,集团将继续与上海复星医药(集团)股份有限公司及其附属公司合作,为公众提供加强疫苗接种剂量。雅各臣主席及行政总裁岑广业先生总结 :「虽然市场环境持续受疫情影响,对各种疾病患者的护理造成干扰,但凭借我们强大的核心业务能力、产品管线和组合,以强大的执行力带动集团于二零二二财年表现强劲。我们为在港澳分销复星BioNTech复必泰疫苗中担任协作角色深感自豪。本地爆发第五波疫情期间,我们致力维持稳健的制造及物流营运,以确保持续向医院及患者供应基础药物。展望未来,我们以良好的势头迈进二零二二年,目标是为打造可预见未来健康需要的独特产品组合。通过开展研发及引进授权策略、建立稳固的伙伴合作关系及于关键战略市场建立据点,我们将进一步推动业务多元化及转型,以实现持续增长,并为股东带来价值。」关于雅各臣科研制药有限公司(股份代号:2633)雅各臣是本地领先的医药公司,拥有垂直整合的业务,包括基础药物及专科药物的研发、生产、分销、销售及物流。作为本地主要的非专利药供货商,集团在香港私营及公营领域,具有最广泛的销售及分销的市场覆盖,并积极向策略性选择的亚洲市场伸延扩展。集团于香港设有10间PIC/S GMP认证的非专利药生产设施,并在各种治疗药物类别中拥有广泛的产品组合与享有优越市场地位。同时,集团一直致力透过增加各种高增值产品,策略性地扩大其非专利药的产品组合。扎根香港,集团已于中国、澳门、台湾及柬埔寨开设营运子公司,建立区域性商业平台,以把握亚太区及大中华地区的市场潜力。而自 2017 年 6月 1 日,集团获纳入 MSCI 香港微型股指数成份股。更多详情请浏览雅各臣科研制药有限公司网站:http://www.jacobsonpharma.com/* 不包括香港政府于二零二一财年发放的一次性保就业计划资助约81.1百万港元 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More
达丰设备服务有限公司公布2022财年全年业绩 ACN Newswire

达丰设备服务有限公司公布2022财年全年业绩

HONG KONG, Jun 29, 2022 - (亚太商讯 via SEAPRWire.com) - 达丰设备服务有限公司(「达丰」或「公司」,连同其附属公司统称「集团」)(股份代号:2153)为在中国成立的首家外资塔式起重机服务供货商,公布其截至2022年3月31日止年度(「2022财年」或「年内」)的全年业绩。2022财年,集团的收益为人民币867.0百万元,较截至2021年3月31日止年度增长9.3%,主要是由于自有及租赁塔式起重机的数量有所增加,而其中大部分起重机一直在现场作业并产生收益。集团的使用总吨米由2021财年的约2,491,629增加至2022财年的3,112,084。年内毛利减少约14.3%至人民币234.1百万元。年内溢利为人民币47.6百万元(2021财年:人民币101.2百万元)。溢利减少主要是由于受2022年3月向最高管理层提供股份奖励计划的会计处理(非现金调整)影响所致。董事会建议派发末期股息每股0.016港元。于2022年3月31日,集团有288个在建项目,未完成合约总值约人民币569百万元,手头项目共有42个,预期合约总值约人民币102百万元。其中,集团预期于截至2023年3月31日止年度完成总值约人民币497百万元的合约工程,显示来年将可录得高水平的盈利。达丰设备服务有限公司行政总裁邱国燊先生表示:「2022财年不仅对我们来说是艰难的一年,对于整个市场也是如此。尽管在疫情防控措施之下,疫苗接种率在各国开始上升,包括中国在内的经济体正在逐步复苏。但全球公共卫生、经济和就业仍受到2019新型冠状病毒病的不利影响。随着疫情在全球持续肆虐,全球市场在疫情下仍面对诸多不确定性。我们将藉此拓展新的市场机会,继续致力为客户提供一站式塔式起重机解决方案服务。」年内,集团通过增购塔式起重机及相关配套零件和部件,藉此扩大业务,以满足日益增长的客户需求。于本公布日期,集团管理合共1,180台塔式起重机,旨在迎合集团客户于中国各地的专业EPC项目。作为一家在中国享负盛名的外资塔式起重机服务供货商,集团在关注工人安全、服务质量及技术优势方面树立了良好声誉。集团目前持有77项与塔式起重机相关的实用新型及发明注册专利。除了提升制造能力外,集团亦持续提升塔式起重机及其附属结构件的再制造及再加工能力,并致力于透过开发数字化管理平台「iSmartCon爱建通」,以提供绿色服务,同时提高营运及管理效率。展望未来,集团将专注于中大型塔式起重机的经营,以满足日益增长的装配式建筑需求;并建立标准化的塔式起重机后市场服务生态系统,为打造绿色、安全及环保的塔式起重机服务产业奠定基础。达丰设备服务有限公司主席黄山忠先生总结:「未来,集团将在有效执行中国防控政策的同时,继续关注2019冠状病毒病疫情的发展,以确保员工安全,并减轻其对集团财务状况及经营业绩的负面影响。我们将继续巩固我们在市场上的优势和领先地位,以把握巨大的市场增长机会,推动可持续的长期业务,为股东带来满意的回报。」 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More
Hypebeast Ltd. (0150.HK) 2022 财政年度收益及盈利能力创历年记录新高 ACN Newswire

Hypebeast Ltd. (0150.HK) 2022 财政年度收益及盈利能力创历年记录新高

HONG KONG, Jun 29, 2022 - (亚太商讯 via SEAPRWire.com) - Hypebeast Limited(股份代号:0150.HK)是一个结合现代文化与生活时尚、以及编辑自主之商业及新闻的首选平台。Hypebeast Limited 董事会公布集团截至 2022 年 3 月 31 日(2022 年财政年度)的业绩报告。-- 收益由2021财政年度之674,200,000港元,增加221,400,000港元或 32.8%至2022财政年度之895,600,000港元。-- 毛利率由2021财政年度之49.6% 增加至2022财政年度之61.3%,上升11.7个百分点。-- 集团于2022财政年度之纯利达100,200,000港元,较2021财政年度增加 41.9%。 纯利率因此提升了0.7个百分点,由2021财政年度之10.5%增加至2022财政年度之11.2%。-- 于2022财政年度,媒体分部已签署合约之总价值较先前年度增加31.7%。-- 12个月之平均网站月度独立访客人 数(一个月内于Hypebeast、Hypebae及 Popbee平台上存取网页的用户人数)达16,400,000人次,较2021财政年度增加5.1%,而社交媒体关注总数(于所有第三方社交媒体平台(包括不限于Facebook、Instagram、Twitter)的关注总数)由2021年3月31日的26,100,000人次增加至2022年3月31日的32,400,000人次。集团于2022财政年度之收益录强劲显著增长,收益及盈利能力更是历年最高。收益由2021财政年度之674,200,000港元,增加221,400,000港元或 32.8%至2022财政年度之895,600,000港元。毛利率由2021财政年度之49.6% 增加至2022财政年度之61.3%,上升11.7个百分点。 集团于2022财政年度之纯利达100,200,000港元,较2021财政年度增加 41.9%。纯利率因此提升了0.7个百分点,由2021财政年度之10.5%增加至2022财政年度之11.2%。 于2022财政年度,市场对集团媒体及代理服务的需求依然殷切,媒体分部已签署合约之总价值较先前年度增加31.7%。COVID-19疫情渐趋平复,疫情相关之限制逐步放寛,集团媒体分部之活动制作工作及线下推广活动更胜COVID-19疫情前及2019财政年度之水平。 集团预计这将增加及扩大媒体合约的数量及规模, 为媒体分部带来正面影响。12个月之平均网站月度独立访客人数(一个月内于Hypebeast、Hypebae及 Popbee平台上存取网页的用户人数)达16,400,000人次,较2021财政年度增加5.1%,而社交媒体关注总数(于所有第三方社交媒体平台(包括不限 于Facebook、Instagram、Twitter)的关注总数)由2021年3月31日的26,100,000人次增加至2022年3月31日的32,400,000人次。集团旨在透过发展新编采业务吸引及触及更广泛之用户顾客群。例如: Hypegolf(专注于高尔夫球及生活时尚)、Hypeart(专注于艺术及艺术家)及 Hypemoon(专注于Web 3.0项目及技术)。集团将透过成立多个线下渠道及接触点,继续发掘相似的机会,以增加与新及现有用户与客户的交流。位于香港中环之HBX实体零售店仍为有力的营销窗户及客户以线下形式参与Hypebeast在线生态的场所。此外,集团于美国的旗舰店已于2022年6月开幕(于随后的财政年度)、楼高七层的旗舰店汇聚于美国东岸办公室、美国纽约HBX旗舰店、Hypebeans咖啡店,以及活动场地。纽约旗舰店落成后,将有助我们凝聚庞大的北美客户群并加快其增长,更有助集中对电子商务及零售分部的营销策略。Hypebeast执行董事、主席兼行政总裁马柏荣表示:“我们在本财政年度之收入和盈利能力再次录得历史新高,充分反映在前所未有的COVID-19疫情之前和期间作出的战略已经得到回报。而2022财政年度的表现正正就是本集团在地理和策略上优越定位的最佳证明,相信亦可以继续捉紧进一步的增长机会。尽管现时还存在许多不确定性,但我们仍然雄心勃勃,专注于透过市场扩张和品类多样化,以及通过我们的电子商务平台和实体店,特别是新开张的HBX纽约旗舰店,提供全方位营销体验,建立和加强Hypebeast的各个业务表现。”本年度财务摘要:2022财政年度 千港元 2021财政年度 千港元收益 895,632 674,212毛利 549,313 334,127毛利率 61.3% 49.6%销售及营销开支 (160,391) (112,791)行政及经营开支 (202,650) (125,005)合并事项的专业费用 (30,185) -EBITDA* 174,252 122,596纯利 100,167 70,584纯利率 11.2% 10.5%每股盈利- 基本(港仙) 4.88 3.47- 摊薄(港仙) 4.87 3.45*扣除利息、税项、折旧及摊销前盈利(「EBITDA」)乃按除税前溢利加上利息开支、折旧、摊销开支计算。欢迎浏览集团官方网页,细阅详尽的年度业绩报告。https://hypebeast.ltd/investors投资者查询:investors@hypebeast.com 媒体查询:media@hypebeast.com 纵横财经公关顾问有限公司李惠儿 电话: (852) 2864 4834电邮: vicky.lee@sprg.com.hk 陈嘉盈 电话: (852) 2864 4890电邮: ivy.chan@sprg.com.hk 公司网址: https://www.sprg.asia/ 关于 Hypebeast (股份代号:0150.HK)Hypebeast 是全球知名的文化及生活潮流信息平台,以编辑为主导的角度提供不同内容及推介最新的潮流商品。Hypebeast 成立于 2005 年,并于 2016 年正式成为上市公司。至今 Hypebeast 在北美、亚太地区以及欧洲等地拥有庞大的读者群。近年 Hypebeast 积极发展更多元化的业务,当中包括 Hypebeast 以及多个信息平台、网上商店HBX.com, 及创意制作公司 Hypemaker。更多信息请参阅 www.hypebeast.ltd。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More
天阶控股和Stellar Lifestyle(胜德丽生活时尚)签署合作协议 ACN Newswire

天阶控股和Stellar Lifestyle(胜德丽生活时尚)签署合作协议

共同开发L.I.F.E全渠道数字化生态系统赋能中小企业的数字智慧经济能力投资2亿新元建设L.I.F.E全渠道数字化生态系统,以新加坡天幕为爆点, 天阶控股打造智慧国家科技基础设施"L.I.F.E. 全渠道数字化生态系统"代表着全方位的、沉浸式的、数字化智能新型的电子商务解决方案;作为"L.I.F.E. 全渠道数字化生态系统"的爆点和龙头,天阶控股将耗资约2亿新元,凭借北京世贸天阶梦幻天幕的深厚技术沉淀和创新能力,打造新加坡的首个数字化天幕,使体验和数字化商务,百尺竿头,更进一步;合作双方致力于参与新加坡智慧国家的建设,在生态系统中整合人工智能、数据资产开发与管理、XR科技、物联网等技术,发展数字化的科技平台;"L.I.F.E. 全渠道数字化生态系统"的目标在于提高人们的生活体验,提高中小企业的数字智慧化能力,开发数字经济的商业潜力,服务于广大消费者;抓住世界数字化市场的新兴机遇,天阶控股和胜德丽生活将携手探索"I.F.E全渠道数字化生态系统"、整合产业链,以新加坡为圆心,迈向全球。Singapore, 2022年6月29日 - (亚太商讯 via SEAPRWire.com) - 新加坡交易所主板上市公司天阶控股 (The Place Holdings Limited)正式宣布与SMRT集团旗下Stellar Lifestyle有限公司 (胜德丽生活时尚)。双方将共同开发"L.I.F.E全渠道数字化生态系统",挖掘数字经济新机遇,共创共享价值,塑造数字生活一体化发展的新未来。From left to right: 天阶控股主席-吉增和先生, 天阶控股首席执行官-樊献勇先生, 胜德丽生活时尚总裁-王友德,SMRT集团主席-佘文民先生作为一家在数字商业管理和沉浸式商业运营领域有着丰富经验的领军企业,天阶控股凭借创新科技提供先进的、超级体验式的市场营销和媒体解决方案,为所在的市场和社区注入全新的商业活力。天阶控股执行主席吉增和说:"如今,数字经济处于加速演进和融合创新的全新阶段,我们积累的技术和经验为未来的新业态、新模式铺平了道路。"位于北京的"世贸天阶梦幻天幕"是天阶控股股东的成名代表作。不但吸引国内外游客纷至沓来,更是北京的活力中心和时尚策源地。作为亚洲最大的数字天幕,该LED屏幕长250米,宽30米。这个交互式的大终端生态不但点亮了7500平方米的天空,也开创了一个全新的生活范式。数字化的媒体解决方案让更多的品牌得到了有效传播,消费场景不断延伸,进而触达更多的参与互动者。目前,北京天幕的IP使用权即将转让给天阶控股,并已上报新交所,为新加坡天幕的落地做好了准备。现在,一个升级版的梦幻天幕即将在新加坡投入建设。作为"L.I.F.E全渠道数字化生态系统"的龙头部分,天阶控股将注入2亿新元的投资完成该数智平台,为新加坡提供极具科技感的、互动沉浸式的城市魅力空间,服务于大型活动、媒介曝光、数字营销、电子竞技、互动游戏等多元内容,为新加坡的城市建设增光添彩。Sky Screen's Artist Impression合作伙伴胜德丽生活是新加坡铁路网络中最大的零售和广告代理公司。通过此次合作,天阶控股将和胜德丽生活强强联手,深度融合,在科技创新联动、产业链供应链协同、基础设施联通、公共服务共享等方面形成一批标志性业态。通过丰富的资讯终端,拓宽信息获取渠道,为消费者带来更精准、更流畅的内容服务,优化通勤体验和生活质量;提高地铁的商业运营能力,满足多场景、多系统下的协同管理需求;以"产业链延伸+标准化运营+数字化技术"赋能新加坡中小企业,完美解决消费者"最后一公里"的痛点,同时将品牌发展推向新阶段。吉增和表示:"我们与胜德丽生活有着共同的愿景,即利用先进的科技和基础设施来改善我们的生活质量,使中小企业能够融入数字时代的商业模式,具备新的可持续成长能力." "L.I.F.E全渠道数字化生态系统"致力于打通城市基础设施、客户和企业之间的连接。它包括五个重点业务平台:天幕生态系统平台、数字与广告平台、镜像商业平台、最后一公里服务平台、信息管理平台。双方的合作计划旨在形成一个全方位的数字信息技术系统,加快城市的数字转型,助力新加坡发展为智能国家的目标。 吉增和补充到:"通过不断改进平台产品和体验,持续共建共生生态圈;我们的目标是响应新加坡智能国家的倡议,服务社区,创造无限的可能性。"如需更多信息,请联系:Mr. Alex TAN Mobile: +65 9451 5252Email: alex.tan@8prasia.com Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More
Hypebeast Ltd. (0150.HK) ended the financial year with another all-time high in revenue and profitability ACN Newswire

Hypebeast Ltd. (0150.HK) ended the financial year with another all-time high in revenue and profitability

HONG KONG, Jun 29, 2022 - (ACN Newswire via SEAPRWire.com) - Hypebeast Limited (Stock Code: 0150.HK) is the global leading platform for contemporary culture and lifestyle, and a premier destination for editorially-driven commerce and news. The Board of Directors of Hypebeast Limited has announced the Group's annual results for the year ended 31 March 2022 ("FY2022"). -- Revenue amounted to HK$895.6 million in FY2022, up from HK$674.2 million in FY2021, representing an increase of HK$221.4 million or 32.8%.-- Gross profit margin rose by 11.7 percentage points from 49.6% in FY2021 to 61.3% in FY2022. -- The Group delivered net profit of HK$100.2 million for FY2022, a 41.9% increase compared to FY2021. The increase translated to an improvement of net profit margin by 0.7 percentage points, resulting in an increase from 10.5% in FY2021 to 11.2% in FY2022.-- Total value in signed contracts for the Media Segment increased by 31.7% during FY2022 as compared to the prior year.-- 12-month average website monthly unique visitors (number of user who requests web pages across Hypebeast, Hypebae and Popbee platforms in a month) amounted to 16.4 million, representing a 5.1% increase over FY2021, and aggregated social media following (total number of followers on all third-party social media platforms, including but not limited to Facebook, Instagram, Twitter) increased from 26.1 million as at 31 March 2021 to 32.4 million as at 31 March 2022.The Group recorded strong revenue growth in FY2022 and reported another all-time high in revenue and profitability. Revenue amounted to HK$895.6 million in FY2022, up from HK$674.2 million in FY2021, representing an increase of HK$221.4 million or 32.8%. Gross profit margin rose by 11.7 percentage points from 49.6% in FY2021 to 61.3% in FY2022. The Group delivered net profit of HK$100.2 million for FY2022, a 41.9% increase compared to FY2021. The increase translated to an improvement of net profit margin by 0.7 percentage points, resulting in an increase from 10.5% in FY2021 to 11.2% in FY2022.Demand for the Group's media and agency services remained strong, with total value in signed contracts for the Media Segment having increased by 31.7% during FY2022 as compared to the prior year. As COVID-19 pandemic's intensity wanes and pandemic-related restrictions continue to ease, the Group's events production and offline partnerships under the Media Segment have surpassed pre-COVID-19 and FY2019 levels. The Group noted increasing demand for offline campaigns and activations as global marketing spend continues to expand. 12-month average website monthly unique visitors (number of user who requests web pages across Hypebeast, Hypebae and Popbee platforms in a month) amounted to 16.4 million, representing a 5.1% increase over FY2021, and aggregated social media following (total number of followers on all third-party social media platforms, including but not limited to Facebook, Instagram, Twitter) increased from 26.1 million as at 31 March 2021 to 32.4 million as at 31 March 2022. The Group aims to attract and reach a wider user-customer base through its development of new editorial properties, such as Hypegolf that focuses on golf and lifestyle, Hypeart on art and artists, and Hypemoon on Web 3.0 projects and technologies. The Group continues to explore similar opportunities by establishing various online and offline channels and touchpoints in order to drive the Group's brand awareness and increase engagement with new and existing users and customers. The HBX physical retail shop located in Central, Hong Kong remains a strong marketing window and attraction point for customers to participate in the Hypebeast ecosystem offline. In addition, the Group's U.S. flagship store opened in June 2022 (subsequent to the reporting financial year), spanning seven floors, housing the U.S. East Coast office, the HBX New York flagship store, a Hypebeans cafee, as well as event spaces. The New York flagship store will support execution and accelerate growth of our strong North American customer base and serve as a focused point of marketing for the E-Commerce and Retail Segment. Kevin Ma, Executive Director, Chairman, and CEO of Hypebeast, said: "We have recorded yet another all-time high in revenue and profitability, showing the strategic choices made both before and during the unprecedented COVID-19 context have paid off. The FY2022 result is the best demonstration of how the Group is geographically and strategically well-positioned to continue to capture further growth opportunities. Despite today's uncertainties, we are ambitious and will continue to focus on building and strengthening all facets of Hypebeast through market expansion, category diversification, and offering an omnichannel experience through our e-commerce platform and physical stores, in particular the newly opened HBX New York flagship store."A breakdown of this year's financial highlight is as follows:FY2022 HK$'000 FY2021 HK$'000Revenue 895,632 674,212Gross Profit 549,313 334,127Gross Profit Margin 61.3% 49.6%Selling and marketing expenses (160,391) (112,791)Administration and operating expenses (202,650) (125,005)Professional fees related to the Merger (30,185) -EBITDA (Note) 174,252 122,596Net profit 100,167 70,584Net profit margin 11.2% 10.5%Earnings per share- Basic (HK cent) 4.88 3.47- Diluted (HK cent) 4.87 3.45Note: Earnings before interest, tax, depreciation and amortization ("EBITDA") is calculated as profit before tax + interest expense + depreciation + amortization expense.For further details on the Annual Results performance, visit the Group's corporate website to view the full results announcement.https://hypebeast.ltd/investorsFor investor inquiries, please contact:investors@hypebeast.com For more information, please contact:media@hypebeast.com Strategic Financial Relations LimitedVicky Lee Tel: (852) 2864 4834 Email: vicky.lee@sprg.com.hkIvy Chan Tel: (852) 2864 4890 Email: ivy.chan@sprg.com.hkWebsite: https://www.sprg.asia/ About Hypebeast Ltd. (Stock Code: 0150.HK)Hypebeast is a leading global platform for contemporary culture and lifestyle, and a premier destination for editorially-driven commerce and content. Founded in 2005, it became a publicly listed media company in 2016 and today boasts a global readership across North America, Asia Pacific, Europe and more. The Group has expanded its publishing brands to a wider scope in recent years, encompassing Hypebeast and its multiple content distribution platforms, e-commerce and physical store HBX, and agency Hypemaker. For more information, please visit www.hypebeast.ltd. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
Main Market-Bound Seng Fong Holdings Berhad IPO Shares Oversubscribed by 3.09 Times ACN Newswire

Main Market-Bound Seng Fong Holdings Berhad IPO Shares Oversubscribed by 3.09 Times

KUALA LUMPUR, Jun 29, 2022 - (ACN Newswire via SEAPRWire.com) - Tricor Investor & Issuing House Services Sdn Bhd (TIIH) is pleased to announce that the Initial Public Offering (IPO) of Seng Fong Holdings Berhad is oversubscribed by 3.09 times.Managing Director of Seng Fong, Mr. Er Hock LaiGroup Managing Director/ Chief Executive Officer of Hong Leong Investment Bank, Ms. Lee Jim LengSeng Fong's IPO involves the issuance of 160,874,300 IPO Shares in the following manner:(A) Retail offering of 42,198,000 IPO Shares to be allocated in the following manner:- 25,948,000 IPO Shares to the Malaysian public; and- 16,250,000 IPO Shares to the eligible directors and employees of Seng Fong and its subsidiaries (Group) and persons who have contributed to the success of the Group;(B) Institutional offering of 118,676,300 IPO Shares to be allocated in the following manner:- 64,870,000 IPO Shares by way of private placement to Bumiputera investors approved by the Ministry of International Trade and Industry ("MITI"); and- 53,806,300 IPO Shares by way of private placement to other institutional and selected investors.A total of 3,968 applications for 106,046,800 IPO Shares with a value of RM79,535,100 were received from the Malaysian public, which represents an overall oversubscription rate of 3.09 times. For the Bumiputera public portion, a total of 2,097 applications for 31,762,400 IPO Shares were received, which represents an oversubscription rate of 1.45 times. For the remaining Malaysian public portion, a total of 1,871 applications for 74,284,400 IPO Shares were received, which represents an oversubscription rate of 4.73 times.Meanwhile, the 16,250,000 IPO Shares available to the eligible directors and employees of the Group and persons who have contributed to the success of the Group have also been fully subscribed.Managing Director of Seng Fong, Mr. Er Hock Lai said, "We would like to thank investors for their response to our IPO as this is an indication of their confidence in the fundamentals of the business. We can now look forward to capture opportunities arising from the increasing demand from existing customers as well as from new customers as we ramp up production through the hiring of more people for a second shift and implementing ESG initiatives to make our business more sustainable."Group Managing Director/ Chief Executive Officer of Hong Leong Investment Bank, Ms. Lee Jim Leng said: "We are pleased with the reception from investors to Seng Fong's IPO reflecting their confidence in the solid fundamentals of the business and in the leadership as well as vision of the founders and promoters." Hong Leong Investment Bank Berhad is the Principal Adviser, Underwriter and Placement Agent for the IPO.The notices of allotment will be posted to all successful applicants on or before 6 July 2022. The company will list on the Main Market of Bursa Malaysia Securities Berhad on 7 July 2022.Seng Fong Holdings Bhd: http://sengfongholdings.com/ Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
Oculis Announces First Patient Enrolled in Phase 3 OPTIMIZE Trial of OCS-01 in the Treatment of Inflammation and Pain Following Cataract Surgery ACN Newswire

Oculis Announces First Patient Enrolled in Phase 3 OPTIMIZE Trial of OCS-01 in the Treatment of Inflammation and Pain Following Cataract Surgery

LAUSANNE, Switzerland, Jun 29, 2022 - (ACN Newswire via SEAPRWire.com) - Oculis S.A., (Oculis) a global ophthalmology company developing life-changing treatments to save sight and improve eye care with breakthrough innovations, today announced that the first patient has been enrolled in its Phase 3 OPTIMIZE (Once-daily Post ocular surgery Treatment for InflaMmation and paIn to minimiZE drops) trial evaluating the efficacy and safety of once-daily OCS-01, a novel, high concentration, preservative-free, topical OPTIREACH formulation of dexamethasone for the treatment of inflammation and pain following cataract surgery.In the completed Phase 2 SKYGGN study, once-daily OCS-01 successfully met its primary endpoint demonstrating superior efficacy and safety vs vehicle (placebo) in the treatment of inflammation and pain following cataract surgery. Positive data from that trial was presented at the American Society of Cataract and Refractive Surgery (ASCRS) 2020 Annual Meeting. Oculis subsequently held a positive end-of-Phase 2 meeting with U.S. FDA which enabled the start of the Phase 3 OPTIMIZE trial. OPTIMIZE is a randomized, double-blind, placebo-controlled Phase 3 trial in 25 participating sites across the US and is scheduled to enroll approximately 240 patients. Efficacy measures of the trial include the absence of anterior chamber cells at Day 15 and absence of pain at Day 4. Treatment of inflammation and pain following ocular surgery is another indication being pursued for OCS-01, following the commencement in November 2021 of the Phase 3 DIAMOND trial investigating OCS-01 in patients with DME.Eric Donnenfeld, M.D. clinical professor of ophthalmology at New York University and Trustee of Dartmouth Medical School, said: "Following cataract surgery, patients often need to self-administer eye drops several times a day to manage inflammation and pain. An efficacious, preservative-free alternative, administered just once a day could provide significant advantages over current options." Riad Sherif, M.D., CEO of Oculis, said: "This is another important development milestone for OCS-01, following the start of our Phase 3 trial in DME last year, which further signals the potential for this novel product candidate to address the limitations of currently available treatments for both retinal and front-of-the-eye indications. Clinical data generated so far have been very encouraging and we look forward to generating further data in this trial to support regulatory submissions."OCS-01 has been developed using Oculis's OPTIREACH solubilizing nanoparticle technology, a proprietary platform that enables the formulation of drugs as non-invasive topical eyedrop treatments, a longer residence time on the eye surface and enhances their bioavailability in the relevant eye tissues, particularly the retina.About OculisOculis is a global biopharmaceutical company purposefully driven to save sight, improve eye care and address significant unmet medical needs with breakthrough innovations. Oculis's highly differentiated pipeline includes candidates for topical retinal treatments, topical biologics and disease modifying treatments. With a presence in key international markets, Oculis is poised to deliver life-changing treatments to patients worldwide. Headquartered in Lausanne, Switzerland and with operations in Europe, the U.S. and China, Oculis is led by an experienced management team with a successful track record and supported by leading international healthcare investors. For more information, please visit: www.oculis.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
Regina Miracle Fiscal 2022 Results Hit Record High, Revenue Increased by 39.7% to HK$8.35 Billion, Adjusted Net Profit More than Doubled to HK$582 Million ACN Newswire

Regina Miracle Fiscal 2022 Results Hit Record High, Revenue Increased by 39.7% to HK$8.35 Billion, Adjusted Net Profit More than Doubled to HK$582 Million

HONG KONG, Jun 29, 2022 - (ACN Newswire via SEAPRWire.com) - Regina Miracle International (Holdings) Limited ("Regina Miracle" or the "Company", together with its subsidiaries, collectively the "Group") (HKEX: 2199), a leading global intimate wear company boasting an Innovative Design Manufacturer ("IDM") business model, has announced its annual results for the year ended 31 March 2022 (the "year" or "Fiscal 2022").During the year, despite the various challenges in the macro environment, the Group's revenue hit a historical high of approximately HK$8,346.7 million (Fiscal 2021: HK$5,974.3 million), representing a year-on-year increase of 39.7%, which was in line with the expected progress of the Group's five-year plan. Gross profit grew correspondingly by 65.2% to approximately HK$2,045.4 million, with the gross profit margin up by 3.8 percentage points to 24.5% (Fiscal 2021: HK$1,238.0 million and 20.7%, respectively). As the satisfactory revenue growth and effective cost control measures resulted in enhanced operating leverage, earnings before interest, taxes, depreciation and amortization (EBITDA) increased by 62.5% to approximately HK$1,333.8 million, with the EBITDA margin up by 2.3 percentage points to 16.0% (Fiscal 2021: HK$820.6 million and 13.7%, respectively). The Group recorded a net profit of approximately HK$520.7 million for the year, representing a year-on-year increase of 314.8%, with the net profit margin up by 4.1 percentage points to 6.2% (Fiscal 2021: HK$125.5 million and 2.1%, respectively). Basic earnings per share attributable to owners of the Company were HK42.5 cents (Fiscal 2021: basic earnings per share of HK10.3 cents). Excluding the one-off expense item arising from the surrender of parts of the leased factory in Shenzhen during the year, the adjusted EBITDA was approximately HK$1,394.9 million with an adjusted EBITDA margin of 16.7%, while adjusted net profit was approximately HK$581.8 million with an adjusted net profit margin of 7.0%.The Group is in a sound financial position, with cash and cash equivalents increasing to approximately HK$995.0 million during the year (Fiscal 2021: HK$828.0 million). It has undrawn banking facilities of approximately HK$2,371.0 million in total as at 31 March 2022 (31 March 2021: HK$2,391.0 million). In order to share the fruitful results with shareholders, the Board has resolved to declare a final dividend of HK7.2 cents per share for Fiscal 2022 (Fiscal 2021: HK3.3 cents per share), together with the interim dividend of HK6.8 cents per share, making a total dividend of HK14.0 cents, in line with the Group's dividend policy of distributing no less than 30% of its net profit for the financial year.Mr. YY Hung, Chairman, Chief Executive Officer & Executive Director of Regina Miracle, said, "While the Pandemic has further reshaped the global landscape, industry leaders with strong R&D capabilities, large scale, rapid response and multi-regional production capacity layout are strongly favored by the market, reflecting the fact that the strong get stronger. Furthermore, highly viscous brand partners have fully resumed their businesses operations and there is a greater demand for innovative designs appealing to consumers. The emphasis on continuous innovation, delivering speed and consistent quality of supply chain partners is gaining importance, while the approach to innovation-led services is increasingly valued and favored. Through six years of investment in innovation, automation and digital production, as well as the refinement of its production capacity layout, Regina Miracle has established a solid business foundation and formulated a five-year plan for Fiscal 2022 to 2026 tapping multiple favorable factors to fully capitalize on this golden period of growth. In the face of the diversified product needs driven by users' changing lifestyles, and increasingly flexible supply chains and production cycles, the Group will continue to focus on various business segments to provide appropriate integrated solutions for different needs."Business ReviewOrders from European and American brand partners have fully recovered, thus the intimate wear segment has soared by more than 60%, exceeding the pre-epidemic levelDuring the year, this segment contributed approximately HK$4,716.0 million in revenue (Fiscal 2021: HK$2,886.0 million), a year-on-year surge of 63.4%, accounting for 56.5% of the Group's total revenue, and remaining the main source of revenue for the Group. The segment's gross profit grew by 94.1% to approximately HK$1,189.2 million, with the gross profit margin up by 4.0 percentage points to 25.2% (Fiscal 2021: HK$612.6 million and 21.2%, respectively). As a result of the better-than-anticipated recovery of the European and U.S. markets during the year, and the strong rebound in orders from the Group's largest U.S. partner, the segment revenue hit a record high, with orders for traditional intimate wear rebounding and surpassing pre-epidemic levels. Drawing on its industry-leading R&D capabilities and innovative craftsmanship, Regina Miracle was able to fully capture the opportunities arising from the easing of the Pandemic, and to work with its major brand partners to seize market opportunities whenever and wherever they arose through flexible production capabilities. In addition, the Group added a number of new emerging PRC e-commerce brands during the year, making its brand partner portfolio more diversified and paving the way for future business growth.The sports product segment remained resilient, with revenue rising by more than 30% year-on-year, with continued product mix enrichmentThis business segment contributed approximately HK$2,190.7 million in revenue during the year (Fiscal 2021: HK$1,596.4 million), a 37.2% year-on-year increase, accounting for 26.3% of total revenue. Segmental gross profit was approximately HK$513.9 million and the gross profit margin was 23.5% (Fiscal 2021: HK$298.9 million and 18.7%, respectively). As the Pandemic eased and the sports craze continued, related products maintained a strong performance, with the order momentum for sports bras from international brand partners being especially strong and thus serving as the main growth driver of this business segment. During the year, the sports leggings product category also showed great momentum through an enriched brand partner portfolio and represented a promising incremental growth driver for the sports products segment. Riding on the emergence of the "Metaverse" concept, the consumer electronics components segment has grown by more than 60% year-on-year, highlighting broad development spaceRevenue from this business segment amounted to approximately HK$496.2 million (Fiscal 2021: HK$291.4 million), representing a significant year-on-year increase of 70.3% and accounting for 5.9% of the Group's total revenue. The segment's gross profit increased by 79.5% to approximately HK$125.0 million, with the gross profit margin up by 1.3 percentage points to 25.2% (Fiscal 2021: HK$69.7 million and 23.9%, respectively). The demand for consumer home electronics continued to rise amid the Pandemic during the year, and with the rapid emergence of the "Metaverse" concept, demand for 5G and related products grew considerably and continuously during the year. As consumer electronics are high value-added products and there is ample room for market development, the segment will continue to generate a new growth impetus for the Group in the future.The revenue from production in Vietnam rose to 80%, with multi-regional production capacity layout fully meeting the enthusiastic demand from domestic and overseas brand partnersAs an important production base of Regina Miracle, Vietnam provides a solid foundation to support the continuous growth of the Group's export business. As of 31 March 2022, the revenue from production in Vietnam rose to 80% of the total revenue of the Group. During the year, the Group completed its factory layout at the Vietnam Singapore Industrial Park in Hai Phong City ("VSIP Hai Phong"), Vietnam. It is worth mentioning that the Group's recruitment and staff stability in the region have been satisfactory, enabling the Group to benefit to the maximum extent from the increasing proportion of mature employees, long service of employees and the master-apprentice model, ensuring that the production capacity and efficiency of each factory will increase year on year. To meet the robust demand of domestic and overseas brand partners as the market resumes, it will be the Group's top priority to continuously enhance the efficiency and effectiveness of its five factories. Through the addition of new production lines and further implementation of automation and digitalization, the overall production capacity in Vietnam will be further increased. After four to six years of integration, the current operation and labor efficiency, as well as the single factory gross margin of the three factories which were first put into operation in Vietnam, have outperformed the three factories put into operation subsequently. According to the rigorous technological authentication conducted by the Company, there is still room for continuous growth and optimization of these factories. Meanwhile, leveraging the actual operational experience of the first three factories in Vietnam, the Group will accelerate the production efficiency of the other factories in Vietnam so as to enhance the consolidated gross margin. The first phase of the facility in Hung Yen Province, Vietnam, which mainly applies seamless knitting technology, officially commenced operation in April 2021 and active recruitment is still in progress. As for domestic operations in China, in order to enhance operational efficiency and optimize its cost structure, the Group surrendered parts of the leased factory in Shenzhen and made a write-off of fixed assets of approximately HK$61.1 million during the year. The aforementioned relocation of the Shenzhen production base to Zhaoqing will further help the Group achieve an optimized production capacity allocation in the long run. The vaccination rates of eligible employees at the Group's production bases in Shenzhen and Hai Phong reached approximately 95% and 90%, respectively, which, to a large extent, will protect the health of employees and the safety of the working environment, while maintaining stable production operations. From the end of 2021 to the beginning of 2022, there were temporary closures and lockdown measures implemented in Shenzhen and Vietnam, respectively, due to a further outbreak of the Pandemic. Thanks to the rapid response of the Shenzhen and Vietnam governments, the Pandemic was soon brought under control. The flexible deployment of human resources by its local managerial team also enabled the Group to minimize the impact of the Pandemic on its production capacity and avoid compromising its ability to fully capture the strong order demand from international and domestic brand partners.Insist on innovation-driven development, to thrive on vast experience, and expand multiple business segments to usher in a golden era of development Faced with a combination of various factors, the industry is up against challenges such as tight supply chains and rising raw material costs, and is undergoing a reshuffle. In this context, Regina Miracle's comprehensive competitiveness in terms of technological barriers, world-leading product innovation capabilities and highly viscous brand-partner relationships established over the years will be further highlighted, laying a solid foundation for future growth and ushering in a golden era of development.Continuous upgrading of core technologies and formation of a win-win and mutually beneficial strategic cooperative relationship with loyal brand partnersOver the years, Regina Miracle has adhered to its IDM business model, supported by its global industry-leading product innovation capabilities. The Group has formed a diversified technological matrix based on three core technologies: computer-aided mold design and production, 3D compression molding, and seamless bonding, with applications spanning various fields such as intimate wear, sports and consumer electronics. The uniqueness, leadership, malleability and versatility of the core technologies allow for a high degree of cross-use by different brand partners in different categories, as well as the ability to cater to the different positioning and needs of each brand and to continue to develop unique and innovative products for the Group's brand partners. This, coupled with the Group's insistence on a mutually beneficial win-win strategy, consistent quality and a high degree of flexibility, has won the trust and viscousness of various brand partners in terms of Regina Miracle's IDM positioning, which will help strengthen the Group's market position in the long run after the industry reshuffle. The Group has also strived to foster and steer the industry trends by continuously strengthening and upholding its technological barriers, registering patents and trademarks for its unique technologies, defining new standards for the industry and providing consumers with a more direct and in-depth understanding of high value-added products, leading the development trend and demand of the market.Realization of the Five-Year Plan blueprint for Fiscal 2022-2026 well underway, promote stability and diversified growth with solid foundationAfter several years of significant investment, Regina Miracle has laid a solid foundation for its future development. In order to lead the Group to a new chapter of development and a brighter future, after giving careful consideration to and conducting a comprehensive review of the market and the businesses, the management has formulated a brand-new five-year plan for Fiscal 2022-2026 focusing on the following areas:I. Drive steady revenue growth: Adhere to the IDM business model to drive steady growth in sales through innovation and R&D, and accelerate the expansion into the PRC market;II. Margin expansion: Continue to develop high value-added and innovative products with better margin, while enhancing management and production efficiency, improving operating leverage as revenue grows and effectuating faster growth in target earnings than in revenue; and III. Sound financial position: Maintain healthy operating cash flows and control capital expenditures through the above measures in order to gradually lower gearing ratio in the medium and long terms, following the completion of the Group's capex intensive investment phase in Northern Vietnam over the last few years.During the year under review, the Group was successful in realizing its target blueprint for Fiscal 2022 set out in its five-year plan, and on the basis of achieving high sales growth, its efficiency and profit margin increased, laying foundation for the Group's medium- and long-term healthy financial position. Based on currently foreseeable orders, the Group remains optimistic that the business will continue to perform well in the first half of 2023. Looking forward, despite numerous uncertainties in the macro-environment, the Group will endeavor to comprehensively achieve the established goals in the five-year plan, fully utilize tailwinds from the advantages of the environment and itself, take stock of the situation and remain flexible to respond, and drive steady rise in the Group's business.At the business level, the Group's future growth will be driven by the four business segments of intimate wear, sports products, consumer electronics components products and footwear:-- The intimate wear business is expected to continue growing steadily. The growth in the intimate wear segment is mainly attributable to the expansion of individual brand partners and the increase in market share of key brand partners, underpinned by the development of innovative craftsmanship products and the product expansion into several sub-categories.-- Growing share of the sports business, with innovative craftsmanship leading the rapid growth in industry demand. In recent years, international brands have become increasingly aware of the importance of the female sports market, of which sports bras are a core product which still has huge development potential. Owing to its foresighted planning several years ago, the Group's strategic partnerships with several leading global brands have become increasingly steadfast and the addition of a number of fast-growing new brands has formed an ideal brand partner portfolio and helped the Group to grasp the growth momentum of the sports intimate wear industry. Meanwhile, Regina Miracle's innovation and R&D capabilities have led to the evolution and upgrading of leggings in the sports segment, significantly enhancing their functionality and comfort, etc. Demand for products in the sports leggings segment is growing significantly and is expected to replicate the growth trajectory of sports bras.-- The consumer electronic components business is showing a trend of diversified development for the coming years to build a more stable product and brand partner portfolio. With the emergence of the "Metaverse" concept, more emphasis is being placed on consumer electronic softgoods products offering a more comfortable, skin-friendly wearing experience that is suitable for prolonged use. The Group is well positioned to apply its innovative craftsmanship and three core technologies in the consumer electronics segment, conducive to develop market-leading products. In addition to the existing international brand partners, the Group introduced domestic leading brand partner during the year with the opportunities for expansion of product categories, driving the growth of consumer electronics components segment of the Group in the coming years. Relevant brand partners have been promptly deploying in this field as well as lengthening their product cycles, resulting in relatively high sales visibility. The Group actively plans and responds to the changing high technology product market through implementing a strategy to diversify its brand partners and product portfolios, laying a flexible and stable foundation for the development of consumer electronics components business.-- The footwear business will continue its steady growth on the current basis. The Group is currently focused on working with an American casual footwear brand. With years of joint development, the partners will continue to go hand in hand and maintain the growth momentum in the foreseeable future.A maturing multi-regional production capacity layout, with advantages of Vietnam as a production base in the global supply chain becoming more prominentIn order to enhance its core competitive advantages, the Group is committed to multi-regional production capacity deployment, bolstering the growth of its export business with its production bases in Vietnam, while promoting the development of the PRC market by leveraging the production bases in China.Against the backdrop of the increasing complexity of global competition and cooperation, Vietnam has become highly sought after by global manufacturing enterprises due to its status as a member state of various trade agreements, its advantages in terms of population size, labor costs and cultural standards, and the local government's commitment to ensuring stable operations for supply chain enterprises. After around six years of strategic deployment for overseas production capacity layout and team cultivation, the Group's production capacity in Vietnam now presents multiple advantages in terms of scale, power, agility and high-quality output. Meanwhile, the implementation of digital management has enabled the Group's deployment of its production capacity to be more coordinated and agile. In addition, Regina Miracle has gradually refined its supply chain localization, including spearheading its core suppliers to accelerate the deployment or expansion of local production capacity in Vietnam, thereby shortening the delivery cycle, improving response time and forming an efficient local problem-solving mechanism, and ultimately optimizing integrated cost efficiency. The Group's competitive advantages are becoming more evident as the industry supply undergoes consolidation.In respect of its business development in the PRC, the Group has also improved production efficiency by promoting automation and digitalization to address the needs of production capacity, strengthening supply chain management, developing local suppliers and ensuring fast delivery, as well as planning production capacity deployment in advance. With the relocation of the Group's R&D center and production base from Shenzhen to the new industrial park in Zhaoqing New District in the Greater Bay Area in phases during the period between mid-2023 and the end of 2024, to produce mainly intimate wear, sports apparel and consumer electronics components with its leading and innovative craftsmanship, the Group will be better positioned to collaborate with international brand partners in tapping the PRC market and to step up efforts to explore new opportunities with emerging online brands in the domestic market and across other channels.Integrating technological innovation and digital intelligence to accelerate penetration into the PRC marketThe intimate wear market in China is characterized by low brand concentration, with most of the existing brands offering a single or relatively narrow product range, while consumer demand is growing rapidly across product segmentation and functional specialization. This industry trend, coupled with the rapid development of e-commerce in the PRC, provides an excellent opportunity for all brands with potential to expand their market share.-- Entered into strategic partnership with Tmall Intimate Wear and TMICIn order to better serve our brand partners that make sales in the PRC and to more quickly identify and address the latest market trends and consumer needs, the Group entered into a strategic partnership with Tmall Intimate Wear and Tmall Innovation Center ("TMIC") on 20 May 2022. TMIC has gained insights into consumer aspirations and feedback from mass purchase activities, forward-looking trend data analysis and a deep understanding of consumer behavior, which helps the Group to carry out specialized and precise R&D, translate consumers' demands into concrete technological solutions and integrate them into end products. Through the joint efforts of the three parties, the Group hopes to achieve the goals of incubating highly reputable and consistently best-selling products that could set new trends, create innovative technology IP, and establish industry standards for specific categories, thereby promoting the healthy and orderly development of the intimate wear market in the PRC.--Established a joint venture with Victoria's Secret to Seize the Opportunities in the PRC marketThe establishment of a joint venture ( "VS China" ) between Regina Miracle and Victoria's Secret & Co. ( "Victoria's Secret" ) in January 2022 also marks a strategic move towards the Group's layout in the PRC market. As the world's largest international intimate wear brand, Victoria's Secret boasts strong consumer brand awareness and mature retail operation and marketing capabilities in the PRC market, which highly complement the Group's strengths in product innovation, research and development and manufacturing, as well as its deep insights into the PRC market and consumers. The joint venture will focus on three main dimensions encompassing product, supply chain and business operations, strengthening the brand in all aspects to better cater for the PRC market. Recently, the range of products that the Group has developed with VS China for the PRC market have been well-received. The first stage of the transformation of the brand's online business has already yielded remarkable results, in which the first launch of "Double-Size 'Jelly-Striped' Bra Top" has seen cumulative sales of more than 250,000 units within four months, while the brand's impact and performance has gradually become more consistent, which clearly demonstrates the synergies between VS China and Regina Miracle in setting the trend for the market.ESG is incorporated into the supervisory responsibilities of the Board and the Group is committed to achieving the 2030 Sustainable Development GoalsIn Fiscal 2022, Regina Miracle officially incorporated ESG into the supervisory responsibilities of the Board, and established an environmental, social and governance committee (the ESG committee), led by the Group's Chief Operating Officer, to strengthen the Board's role in overseeing ESG policies, and facilitate better planning for the management and achievement of the Group's sustainability goals. During the year, the Group decided upon six key issues of concern, including climate action, life on the land, clean water and sanitation, responsible consumption and production, decent work and economic growth, and gender equality, based on the United Nations' 2030 Sustainable Development Goals. In response to these six major directions, the Group has set itself four goals for 2030, namely carbon reduction, waste management, sustainable innovation, and people and community. Regina Miracle will continue to be committed to promoting environmental and social sustainable development, creating long-term value for all stakeholders and assuming its social responsibility with a responsible attitude.Mr. Hung concluded: "With years of perseverance in innovative design and manufacturing, Regina Miracle has successfully established solid technological barriers and developed market-leading products. In the future, the Group will continue to give full play to its advantages in various aspects and pursue win-win situations with its brand partners. At the same time, the Group will continue to be committed to fulfilling its social responsibilities and contributing to the enhancement of the environment, employees and the community, thereby achieving sustainability and delivering long-term value for shareholders and stakeholders. The Group's encouraging performance during the year is attributed to the tireless efforts and dedication of the management team and colleagues. The Group would also like to express its sincere gratitude to the brand partners, supply chain partners and the shareholders for their unwavering support in overcoming the challenges created by the Pandemic. The management is confident that the Group can sustain its growth momentum in the future, further achieve the goals set out in its five-year plan, and move closer towards a golden era of development."About Regina Miracle International (Holdings) LimitedFounded in Hong Kong in 1998, Regina Miracle International (Holdings) Limited is a global leader in the intimate wear manufacturing industry. Adopting the innovative design manufacturer ("IDM") business model, Regina Miracle offers its world-renowned brand partners diverse products, including intimate wear, sports products, consumer electronics components, bra pads and moulded products, footwear and fabric masks. The Group has two strategic strongholds - its R&D and production base in Shenzhen, China, and a major production base in Vietnam, where the Group has expanded production capacity since 2016. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
维珍妮2022财年业绩创历史新高 收入增39.7%至83.5亿港元 经调整后纯利升逾两倍至5.82亿港元 ACN Newswire

维珍妮2022财年业绩创历史新高 收入增39.7%至83.5亿港元 经调整后纯利升逾两倍至5.82亿港元

HONG KONG, Jun 29, 2022 - (亚太商讯 via SEAPRWire.com) - 全球领先的贴身内衣创新设计制造商(Innovative Design Manufacturer,「IDM」)维珍妮国际(控股)有限公司(「维珍妮」或「公司」,连同其附属公司,统称「集团」)(股份代号:2199)公布截至2022年3月31日止年度(「年内」或「2022财年」)全年业绩。年内,纵然面对宏观环境的种种挑战,本集团仍录得创歴史新高的收入约港币8,346.7百万元(2021财年:港币5,974.3百万元),按年增加39.7%,符合集团于五年计划中的预期发展进度。毛利相应增加65.2%至约港币2,045.4百万元,毛利率亦上升3.8个百份点至24.5%(2021财年:分别港币1,238.0 百万元及20.7%)。收入增长理想,加上有效的成本控制措施,使经营杠杆增强,息税折旧及摊销前利润(EBITDA)增加62.5%至约港币1,333.8百万元,EBITDA率提升2.3个百份点至16.0%(2021财年:分别港币820.6百万元及13.7%)。本集团年内录得纯利约港币520.7百万元,按年上升314.8%,纯利率亦上升4.1个百份点至6.2%(2021财年:分别港币125.5百万元及2.1%)。本公司拥有人应占每股基本盈利为42.5港仙(2021财年:每股基本盈利10.3港仙)。撇除年内因退租部分深圳厂房而产生的一次性开支项目,经调整后 EBITDA为约港币1,394.9百万元,经调整后EBITDA率为16.7%;而经调整后纯利为约港币581.8百万元,经调整后纯利率为7.0%。本集团财务状况稳健,年内现金及现金等价物上升至约港币995.0百万港元(2021财年:港币828.0百万元)。于2022 年3 月31日,未提取银行贷款融资总额约港币2,371.0百万元(2021 年3 月31 日:港币2,391.0百万元)。为与股东分享成果,董事会议决建议就2022财年宣派末期股息每股7.2港仙(2021财年:每股3.3港仙),连同中期股息每股6.8港仙,总股息为14.0港仙,以贯彻本集团分派财政年度纯利不少于30%的股息政策。维珍妮主席、首席执行官兼执行董事洪游奕先生表示:「疫情进一步重塑全球布局,市场更为青睐研发实力雄厚、具备规模、快速反应及多区域产能布局的行内领先企业,强者恒强日趋明显;另一方面,深度绑定的品牌伙伴已经全面恢复业务,对能打动消费者的创新设计需求更为殷切,对于供应链伙伴在持续创新、快速交期、稳定质量要求上的权重逐步转变,以创新为首的服务体系愈被重视及青睐。经过六年来对创新、自动化及数码化生产、完善产能布局等方面的投入,维珍妮已奠定稳健的业务基础,因此综合多项有利因素制定2022至2026财年的五年规划,务求全力把握黄金发展期。该等就未来五年销售的目标,及生产效率及营运杠杆的提高,所带来的协同效应将有效提升本集团盈利能力,从而充分推动现金流的良性循环,以稳健的财务状况支撑未来的业务拓展。面对用户生活方式的转变令产品需求转向多元化,供应链及生产周期日益灵活,本集团将继续于多个业务板块发力,为不同需求提供适切的综合解决方案。」业务回顾欧美品牌伙伴订单全面复苏,贴身内衣分部飙逾六成,超疫情前水平此分部于年内贡献约港币4,716.0百万元的收入(2021财年:港币2,886.0百万元),按年飙升63.4%,占本集团总收入56.5%,为本集团的主要收入来源。分部毛利增加94.1%至约港币1,189.2百万元,毛利率提升4.0个百分点至25.2%(2021财年:分别为港币612.6百万元及21.2%)。随着欧美零售市场于年内复苏进度胜预期,加上本集团最大美国品牌合作伙伴的订单强势反弹,带动分部收入创历史新高,其中传统贴身内衣整体订单全面回升,已经超越疫情前水平。凭借领先行业的研发能力及创新工艺,维珍妮得以全面把握随疫情缓和而来的各种机遇,配合灵活的生产能力,与各大品牌合作伙伴携手抢占市场先机。此外,本集团于年内增添数家国内新兴电商品牌,使品牌伙伴组合更多元化,为未来业务增长作准备。运动产品分部保持强韧,收入按年升超三成,产品组合持续丰富此业务分部于年内贡献收入约港币2,190.7百万元(2021财年:港币1,596.4百万元),按年上升37.2%,占总收入26.3%。分部毛利为约港币513.9百万元,而毛利率为23.5%(2021财年:分别为港币298.9百万元及18.7%)。纵然疫情缓和,运动热潮依然持续,相关产品表现强韧,尤其是来自国际品牌合作伙伴的运动胸围订单势头强劲,成为此业务分部的主要增长动力。年内,本集团的运动紧身裤品类新增更多元化的品牌伙伴,令该品类表现亮眼,并使运动产品业务分部增添了另一亮眼增长点。「元宇宙」概念炙热,消费电子配件分部按年增逾六成,发展空间广阔此业务分部的收入约港币496.2百万元(2021财年:港币291.4百万元),按年攀升70.3%,占本集团总收入5.9%。分部毛利增加79.5%至约港币125.0百万元,毛利率提升1.3个百分点至25.2%(2021财年:分别为港币69.7百万元及23.9%)。家用消费电子产品的需求在年内受疫情带动而持续上升,加上「元宇宙」概念迅速冒起,市场对5G产品及相关产品需求可观并节节上升。消费电子产品市场发展空间庞大,且属于高增值板块,该业务分部未来将持续为本集团注入新增长动力。越南产值扩大至八成,多区域产能布局全面满足海内外品牌伙伴殷切需求越南作为维珍妮重要的生产基地,为本集团不断扩张的出口业务提供了坚实支撑。截至2022 年3 月31日,越南生产占本集团总收入的比例已扩大至80%。年内,本集团于越南海防市越南新加坡工业园(「海防VSIP」)内的厂房布局已完成。值得一提的是,本集团在当地的招聘及人员稳定性一直保持理想,使本集团可以最大程度受惠于成熟同事比例的不断提升、长期效力及以老带新模式,确保各厂产能效率逐年爬升。为应对市场回暖后国内外品牌伙伴的殷切需求,提升园内五家厂房的效率及效益仍然是目前的首要任务。透过增加生产线及进一步推行自动化及数码化,厂房的整体产能获得提升。其中,越南率先开始投产的三间厂房经过过去四到六年整合,目前营运及人员效益和单厂毛利率明显超越后来投产的三间厂房。根据公司严谨的技术论证,该几个厂房仍有持续增长和优化空间。同时,本集团将参考越南首三间厂房的实际运作经验,加速配置越南其余几个厂房的产能效率,以提升综合毛利率。至于主要应用无缝针织机技术的越南兴安省厂房一期自2021 年4月正式投产,并正在积极进行招工。而于中国国内,为提高营运效益和优化成本结构,本集团于年内退租部分深圳厂房,因而录得约港币61.1百万元的固定资产撇账。而前述将深圳厂房迁至肇庆之举措,长远将有助集团进一步优化产能配置。本集团深圳及海防生产基地合资格员工的新冠疫苗接种率分别达到约95%及90%,大大度保障了同事的自身健康及工作环境的安全,并维持生产运作稳定。2021年底至2022年初,深圳和越南分别出现因疫情反复而实施的短暂封城和隔离措施。有赖两地政府反应迅速,疫情在短时间内得以受控,加上当地管理团队灵活调配人力资源,对本集团的产能影响轻微,无阻维珍妮全面把握来自海内外品牌合作伙伴的强劲订单需求。坚持创新驱动发展,厚积薄发,多板块业务拓展,迎来黄金发展期在各种错综复杂的因素下,业界同时面对供应链紧张、原材料成本上涨等挑战,正经历重新洗牌的阶段。在这情况下,维珍妮多年来在技术壁垒、全球行业领先的产品创新能力、高黏性的品牌伙伴合作关系等方面累积的综合竞争力将进一步凸显,为未来增长奠定坚实基础,迎来黄金发展期。核心技术不断升级,形成高黏性的品牌伙伴互利共赢战略合作关系维珍妮多年来坚持IDM业务模式,成就了其在全球行业领先的产品创新能力。本集团已经形成以三大核心技术 - 计算机模具设计与制作、立体模压成型、无缝黏合为基础的多元化技术储备矩阵,应用横跨贴身内衣、运动、消费电子等多个领域。核心技术的独特性、领先性、可塑性、通用性使不同品牌伙伴在不同品类中交叉复用程度颇高,亦能同时兼顾各品牌的不同定位和需求,持续为合作品牌伙伴定制开发独特的创新产品。加上集团坚持互利共赢策略、长期稳定的质量及高度的灵活性,建立了各大品牌伙伴对维珍妮IDM定位的信赖及黏性,长远有利于强化本集团在行业洗牌后的市场地位。本集团亦着力于行业趋势的拓展和引导,不断强化并维护自身技术壁垒,为独有技术注册专利和技术标,为行业定义新标准,同时让消费者对于高附加值的产品有更直接深入的认知,引领市场的发展方向及需求。已初步实践2022 至2026财年五年规划,以坚实基础驱动业务稳健及多元化增长经过过去几年重大的投资期,维珍妮已为未来的发展奠下坚实基础。为引领本集团迈向发展的新篇章及更广阔的未来,经过周详考虑及全面审视市场和业务情况后,管理层在本财年之初制定了2022 至2026财年的新五年规划,聚焦以下三大范畴:I. 带动收入增长:坚持IDM业务模式,以创新研发推动销售稳步增长,加速布局中国市场;II. 扩大边际利润:持续开发具有更佳利润率的高附加值创新产品,同时提升管理及生产效率,并随收入增长增强经营杠杆,实现目标盈利增长大于收入增长;及III. 强化财务状况:随着集团过去几年于越南北部投资的资本开支高峰期完成后,透过上述举措保持健康的经营现金流和控制资本开支,中长线逐步降低负债比率。回顾年内,本集团成功实现五年规划为2022财年度所订下的目标蓝图,于推进销售额高速增长的基础上,实现了效率及利润率提升,为继续优化集团中长期财务稳健状况打好根基。集团按目前可预视的订单情况,对2023上半财年业务保持理想表现维持乐观。展望未来,纵然面对大环境存在众多不确定因素,集团仍将致力于2023-2026财年继续全方位实践五年规划内的既定的目标,充分利用环境及自身优势带来各项利好因素,审时度势并保持灵活应对,以驱动集团业务持续稳步上扬。在业务层面,本集团未来的增长将由贴身内衣、运动、消费电子类配件产品及鞋类产品四大业务板块推动:-- 贴身内衣业务未来有望持续平稳增长。贴身内衣板块的增长主要来源自个别品牌伙伴的拓展、大品牌伙伴市场份额的上升,有赖于创新工艺产品开发以及细分品类的产品拓展。-- 运动业务占比持续提升,创新工艺引领行业需求快速增长。国际品牌近年对女性运动市场愈发重视,而运动胸围作为其中一项核心产品,仍存在庞大的发展空间。得益于数年前的高瞻规划,本集团与若干头部国际品牌的战略合作关系日益稳健,亦增添了一些快速增长的新品牌,巩固品牌伙伴组合,成功把握运动内衣行业的增长势头。与此同时,维珍妮的创新研发能力,带领了运动板块中紧身裤的演化和升级,显著提升其功能与舒适度等,此领域的产品需求正蓄势起飞,运动紧身裤业务有望复制运动胸围的增长轨迹。-- 消费电子配件业务未来几年趋向多元化发展,建立更稳健的产品和品牌伙伴组合。随着「元宇宙」概念的兴起,消费电子产品日益重视运用舒适亲肤材料造出更适合用户长期使用的体感功能,而本集团恰好能将创新工艺及三大核心技术应用在消费电子类领域,开发出引领市场的产品。除了现有国际品牌伙伴外,本集团年内亦新增了国内领先品牌伙伴,同时迎来了跨产品类别拓展的机遇,从而推动集团于消费电子配件业务未来数年的增长。相关品牌伙伴已率先在此领域部署,拉长产品周期,形成较高的销售能见度。通过实现合作伙伴以及产品的多元化策略,积极部署应对高科技产品市场日新月异的本质,为消费电子配件业务发展奠定灵活且稳定的基础。-- 鞋类业务将在现有基础上继续稳步增长。本集团目前专注与美国休闲鞋履品牌合作,双方于过去数年共同成长,可见未来将继续携手向前,保持良好的发展势态。多区域产能布局日趋成熟 越南基地于全球供应链之优势愈发凸显为提升核心竞争优势,本集团致力开展多区域产能布局,以越南的生产基地支持出口业务增长,并依托中国的生产基地推动国内市场的发展。在全球竞合关系愈趋复杂的环境下,越南作为多个贸易协议的成员国,加上人口规模、人力成本、文化水平等多方面的有利条件,且当地政府力保供应链企业的稳定经营,因此备受全球制造业企业追捧。经过约六年的海外产能布局策略部署和团队培养,本集团在越南的产能已经集规模、爆发力、灵敏度、高质量输出的多项优势;同时数码化管理的推行,令本集团的产能宏观统筹调配更加协调和灵活。此外,维珍妮已逐渐完善本地化的供应链,包括引领核心供货商伙伴加速在越南当地的产能布局或扩充,从而缩短交付周期,提升反应速度,形成高效的本地化问题解决机制,最终逐步优化综合成本效益。在行业供应整固下,本集团的优势因而更见突显。针对中国业务的发展,集团亦通过自动化及数码化的推行,提高生产效率,应对产能需求;加强供应链管理,开发本地供货商,快速交期;以及提前规划好产能部署。随着本集团的研发中心及生产基地于2023年中至2024年底期间逐步由深圳迁往大湾区的肇庆新区产业园,新生产基地将主力生产贴身内衣和运动类产品及消费电子配件,配合独占鳌头的创新工艺,将有助加强本集团与国际品牌伙伴在国内市场的合作,以及把握与国内市场新兴在线品牌及来自其他渠道的新机遇。技术创新和数智化结合,加速布局中国市场中国的内衣市场现时品牌集中度较低,大部分现有品牌产品品类也比较单一或相对狭窄,而消费者的需求增长却非常的快,既有细分品类的需求,又有产品功能专业化的需求,加上国内电商的高速发展,为所有具潜力的品牌提供了绝好拓展市场占有率的机会。-- 与天猫内衣及TMIC达成战略合作为加强服务在中国销售的品牌伙伴,以及加速发掘和满足最新的市场趋势及消费者需求,集团于2022年5月20日与天猫内衣及TMIC(天猫新品创新中心)达成战略合作。TMIC通过海量的购买、具前瞻性的趋势数据分析和消费者洞察提炼出消费者的要求及反馈,有助本集团通过专项及精准研发,将消费者的要求转化为具体的技术解决方案,并融合在终端产品中。本集团希望透过三方合力,达成口碑绝佳、持续热销的新趋势产品孵化、创新技术内容IP的打造、共建细分品类行业标准等几项目标,以推动国内内衣市场长远健康有序的发展。-- 与Victoria’s Secret成立合资公司把握中国市场机遇维珍妮于2022 年1月宣布与Victoria’s Secret & Co. (「Victoria’s Secret」)成立合资公司(「VS China」)亦为集团布局中国市场其中的策略一步。Victoria’s Secret作为全球最大的国际内衣品牌,在中国市场同样也拥有强大的消费者品牌认知度,以及非常成熟的零售运营及市场推广能力,配合本集团于产品创新、研发及制造的强大能力,以及对中国市场和消费者的深刻认知,形成强强连手。合资公司将以产品、供应链、业务运营三大体系为重心,致力加强提升品牌更迎合中国市场。近期本集团与VS China所开发的一系列适合中国市场的产品反应热烈,第一阶段针对在线业务的变革取得显著成效,同比合作前品牌销售增长可观,合作后首推的双尺码果冻条小背心,短短四个月内累计销量超过25万件,品牌影响及业绩表现逐渐趋于一致,印证VS China与维珍妮强强连手引领市场的能力。ESG纳入董事会监察 致力实现2030目标维珍妮2022财年把ESG 正式纳入董事会监督职责,成立了由本集团首席营运官领导的ESG委员会 (ESG committee),加强董事会对ESG 政策监管的角色,促进本集团更有规划地管理及实现可持续发展目标。年内,本集团以联合国2030年可持续发展目标为蓝本,规划出六大重点关注议题,包括气候行动、陆地生物、清洁饮水和卫生设施、负责任消费和生产、体面工作和经济增长和性别平等,并因应这六个大方向,为自身制定了2030年四大目标,分别为减碳、废物管理、可持续的创新发展和人才及小区四个层面。维珍妮将继续致力推动环境和社会的可持续发展,以负责任的态度为所有利益相关者创造长期价值及承担社会责任。洪先生总结:「凭借多年对创新设计制造的耕耘,维珍妮成功建立坚实的技术壁垒,开发出引领市场的产品。未来,本集团将继续致力发挥多方面的优势,与品牌合作伙伴共创双赢。与此同时,本集团亦将继续积极承担社会责任,为提升环境、员工及小区条件作出贡献,透过实现可持续发展,为股东及各持份者创造长远价值。本集团于年内实现令人鼓舞的业绩,有赖管理团队及同事们的不懈努力和付出。本集团亦衷心感谢品牌合作伙伴、供货商伙伴及业务合作伙伴,以及股东的鼎力支持,让我们成功驾驭疫情所带来的种种挑战。管理层有信心本集团未来能延续增长势头,进一步实现五年规划所订下的目标,继续迈向黄金发展期。」有关维珍妮国际(控股)有限公司维珍妮国际(控股)有限公司于1998年在香港创立,是全球领先的贴身内衣制造商。透过采用创新设计制造(IDM)业务模式,维珍妮为国际知名品牌合作伙伴提供多种产品,包括贴身内衣、运动产品、消费电子配件、胸杯及模压产品、鞋类及布口罩。集团拥有两大策略据点 ──中国深圳的研发及生产基地,以及越南自集团于2016年扩产后成为重要的生产基地。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More
Infinera and NEC to Modernize Neutral Networks’ Mexico to United States Fiber Optic Network with Industry-leading ICE6 800G Solution JCN Newswire

Infinera and NEC to Modernize Neutral Networks’ Mexico to United States Fiber Optic Network with Industry-leading ICE6 800G Solution

San Jose, Calif., Mexico City and Tokyo, Jun 29, 2022 - (JCN Newswire via SEAPRWire.com) - Infinera (NASDAQ: INFN) and NEC Corporation (TSE: 6701) announced today that Neutral Networks deployed Infinera's ICE6 technology for its new transnational neutral fiber optic network NEXT. The companies worked closely together to design the largest optical network modernization between Mexico and the United States, making it the largest project of its kind in the region within the last 20 years. With Infinera's ICE6 800G coherent technology, Neutral Networks' NEXT network will provide high capacity services and paves the way for future growth in the region.Neutral Networks provides connectivity to carriers, data centers and enterprise customers on its existing 175-mile network. With NEXT, Neutral Networks will establish a neutral, diverse, 100% underground and ultra-low latency fiber network to connect the City of Laredo in the United States with the City of Monterrey in Mexico. Leveraging Infinera's ICE6 technology on the GX Series Compact Modular Platform, NEXT increases the capacity of the international network to meet the rapidly growing bandwidth demands in the region. The network will aggregate and transport 10G and 100G Ethernet services onto high-speed wavelengths across more than 175 miles from Mexico to the United States without regeneration.Infinera's ICE6 is easy to deploy and provides the greatest capacity at the greatest reach, resulting in seamless services, lower costs and power per bit, and enables Neutral Networks to provide more services per fiber. NEC provided end-to-end integration services, underpinned by over 20 years of experience in the optical domain, and comprehensive knowledge of the solutions being offered. This is in addition to being recognized by Infinera as 'Global Partner of the Year' for three consecutive years."Our goal is for Mexico to have a modern, world-class network infrastructure which is why we found Infinera's innovative ICE6 solution and NEC's local engineering capabilities a reliable and ideal fit to ensure a seamless implementation at a scale of this kind," said Noe Garza, CTO at Neutral Networks. "Our NEXT network is revolutionizing the telecoms industry in Mexico, contributing to its growth and providing the most advanced border-crossing network available with Laredo, Texas serving as a key access point to Mexico's international clients.""We are delighted to collaborate with NEC to design and build NEXT, Neutral Networks' next generation network, which will be a critical foundation for internet traffic between the US and Mexico," said Nick Walden, Senior Vice President of Worldwide Sales at Infinera. "This is one of the most important telecom investment projects in the Northeast part of Mexico in recent history, and we are proud to have Infinera's ICE6 industry-leading technology part of this transnational upgrade. ICE6 is deployed worldwide, and this deployment continues to demonstrate the solution's scalable and flexible services to meet growing bandwidth demands.""We are pleased to have joined forces with Infinera to deliver transformational solutions for Neutral Networks' massive transnational backbone," said Hideyuki Ogata, General Manager of the Service Provider Solutions Department at NEC Corporation. "Capitalizing on our regional reach and optical network competence based out of our 5G Transport Network Center of Excellence (CoE) in LATAM, NEC will continue implementing and operationalizing bespoke networks in the region with state-of-the-art solutions that meet diversified customer needs."About NEUTRAL NETWORKSNeutral Networks is a Mexican company focused in providing 100% neutral connectivity to carriers, service providers and operators. It offers turnkey infrastructure services for the telecommunications market, including leasing of dark fiber, lit fiber, internet, and long-haul solutions. Its mission is to close the great gap that exists between infrastructure and consumer demand, to help our country become one of the best-connected countries in the world. Neutral Networks is part of Southern Cross Group, one of the largest private equity funds in the region. Learn more at www.neutralnetworks.mx.About NEC CorporationNEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of "Orchestrating a brighter world." NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at www.nec.com.About InfineraInfinera is a global supplier of innovative open optical networking solutions that enable carriers, cloud operators, governments, and enterprises to scale network bandwidth, accelerate service innovation, and automate network operations. Infinera solutions deliver industry-leading economics and performance in long-haul, submarine, data center interconnect, and metro transport applications. To learn more about Infinera, visit www.infinera.com, follow us on Twitter and LinkedIn, and subscribe for updates. Copyright 2022 JCN Newswire. All rights reserved. (via SEAPRWire)
More
2022 Shaoxing Famous Products International Online Exhibition Launch Ceremony and CCOIC Shaoxing Chamber of Commerce RCEP Forum Was Successfully Held ACN Newswire

2022 Shaoxing Famous Products International Online Exhibition Launch Ceremony and CCOIC Shaoxing Chamber of Commerce RCEP Forum Was Successfully Held

Shaoxing, China, June 29, 2022 - (ACN Newswire via SEAPRWire.com) - On June 28, 2022 Shaoxing Famous Products International Online Exhibition Launch Ceremony and CCOIC Shaoxing Chamber of Commerce RCEP Forum was successfully held. This kicked off a series of 12 online cloud exhibitions for 6 months, targeting different industries and overseas markets.The event was held both online and offline with Mr. Shi Huifang, Mayor of Shaoxing City, Mr. Chen Zongyao, Chairman of CCPIT Zhejiang, Mr. Xia Wendi, Chairman of China National Machinery Industry International Co. (SINOMACHINT), Mr. Tao Guanfeng, Executive Vice Mayor of Shaoxing City and other relevant leaders of Shaoxing City present offline. Mr. Deny Wachyudi Kurnia, Consul General of Consulate General of Indonesia in Shanghai, Mr. Hussain Haider, Consul General of Consulate General of Pakistan in Shanghai, Ms. Tran Ha Trang, Consul of Consulate General of Vietnam in Shanghai, ASEAN China Chamber of Commerce and Industry, Association of Belt and Road Malaysia, India China Regional Exchanges and Trade Investment Center and other overseas guests and representatives of business associations attended the meeting online.Mr. Shi Huifang, Mayor of Shaoxing City, pointed out in his speech that Shaoxing is a traditional foreign trade city that plays an important role in promoting economic and social development. This year marks the first year of RCEP; Shaoxing should take this opportunity of RCEP to become a model city of RCEP. Through this event, we will effectively use the wisdom of experts to analyze the opportunities and challenges faced by Shaoxing in the context of RCEP, further expand economic and trade exchanges, deepen industrial cooperation, and promote the city's foreign trade to a broader field and deeper level.Mr. Chen Zongyao, Chairman of CCPIT Zhejiang, said the organization of "online exhibition" is an important measure to help enterprises stabilize foreign trade, expand the market and get orders. The Shaoxing Famous International Trade Cloud Exhibition and the RCEP Forum are essential to help enterprises understand more deeply the international economic and trade rules, avoid business risks, open their minds and broaden their horizons for participating in international economic and trade cooperation and developing international markets, taking RCEP's entry into force as an opportunity.Mr. Xia Wendi, Chairman of SINOMACHINT, said that SINOMACHINT, one of the largest central enterprises in China's exhibition industry with nearly 70 years of experience organizing and running exhibitions abroad, will give full play to its global overseas resources. It will optimize and innovate the online exhibition mode, focus on key countries, advantageous industries and special regions to build country exhibitions, professional exhibitions and special exhibitions, and help enterprises get more orders with online channels.Mr. Hussain Haider, Consul General of Consulate General of Pakistan in Shanghai, Mr. Deny Wachyudi Kurnia, Consul General of Consulate General of Indonesia in Shanghai, Ms. Tran Ha Trang, Consul of Consulate General of Vietnam in Shanghai are important to guest speakers. They have expressed their willingness to contribute to the stable growth of Shaoxing's foreign trade exports and to promote the mutual development of economic and trade cooperation under the covid-19 pandemic prevention and control.2022 Shaoxing Famous Products International Trade Online Exhibition was broadcast through the 12 cloud exhibition catalog video. The series of exhibitions involve equipment manufacturing, textile and clothing, textile new materials, health environment, consumer goods and gifts, pharmaceuticals, medical, integrated circuits and other industries. It focuses on the three traditional industries of textile, chemical and metal processing and develops four new industries of high-end equipment, electronic information, modern medicine and new materials to promote the development of Shaoxing's advantageous industries.At the scene, Shaoxing Municipal Commerce Bureau, CCPIT Shaoxing, CCOIC Shaoxing Chamber of Commerce and CMEC International Exhibition Co., Ltd., Association of Belt and Road Malaysia signed strategic cooperation agreements with 10 trade service organizations and overseas trade associations to further enhance cooperation and provide more practical services for enterprises in different countries.2022 Shaoxing Famous Products Textile Machinery Industry (Pakistan) International Online Exhibition, the first exhibition of the series, was also opened and launched at the same time. During the exhibition, more than 40 famous Shaoxing textile machinery enterprises such as Zhejiang Taitan, Zhejiang RIFA Textile Machinery, Zhejiang Jinggong Technology, etc. will have one-to-one online negotiations with 100 buyers from Pakistan and procure textile machinery, textile machinery auxiliary machines and accessories, textiles, textile raw materials and other textile industry chain products. The online trade fair will also be promoted through a number of domestic and international mainstream media and social media platforms to greatly enhance exhibitors' exposure and attract quality buyers to participate in the matchmaking negotiations.Contact:Ms. Xuejiao Li, CMEC International Exhibition Co.,Ltd.Email: lixj@cmecexpo.comWebsite: www.shaoxingyunzhan.comTelephone: +8613552313831 Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
Fujitsu Recognized as Winner of 2022 Microsoft Education Partner of the Year Award JCN Newswire

Fujitsu Recognized as Winner of 2022 Microsoft Education Partner of the Year Award

TOKYO, Jun 29, 2022 - (JCN Newswire via SEAPRWire.com) - Fujitsu today announced that it has won the 2022 Microsoft Education Partner of the Year award. Fujitsu was honored among a global field of top Microsoft partners for demonstrating excellence in innovation and implementation of customer solutions based on Microsoft technology."Fujitsu is thrilled to be recognized by Microsoft for our contribution working with clients and partners in supporting over a million students across North America. This helped improve learning environments for students from all different backgrounds to reduce the disruption in education caused by COVID." said Cathy McCann, Vice President Head of Trusted Society, Uvance Unit, Fujitsu. "This initiative underlines the important role we believe technology and global companies, such as Fujitsu and Microsoft, can play by working together to support educators worldwide, as they strive to improve education equity and access for everyone."The Microsoft Partner of the Year Awards recognize Microsoft partners that have developed and delivered outstanding Microsoft-based applications, services and devices during the past year. Awards were classified in various categories, with honorees chosen from a set of more than 3,900 submitted nominations from more than 100 countries worldwide. Fujitsu was recognized for providing outstanding solutions and services in the Education category.In presenting this award, Microsoft recognizes Fujitsu for its ongoing efforts in North America and skill in working in collaboration with Microsoft and ISV community partners, in particular Follett School Solutions, to use Microsoft Azure services to produce outstanding outcomes for Fujitsu's education clients in Canada and the United States.At the height of the Covid-19 pandemic, Fujitsu leveraged its SIS to support tens of thousands of educators and over 1M students in North America. This helped to digitally transform administrative operations and completely reorganize classroom courses to be run online in a matter of days. This allowed teachers to introduce new services and provide continuity for all students and parents at a time of extraordinary uncertainty.Based on SIS, Fujitsu successfully implemented and manages "MyEducation BC," a province-wide service shared by teachers, school officials and by over 650,000 students and parents in over 2,000 schools in all 60 School Districts and many private schools across British Columbia. Another provincial service based on SIS, "MySchoolSask", supports all 27 School Divisions with 205,000 students across the Province of Saskatchewan. Despite sudden, unexpected changes and significant workload spikes on the SIS, both environments have performed without disruption, delivering full security and privacy compliance, as well as peace of mind to school administrators.Moving forward, Fujitsu will continue to promote partnerships with stakeholders, including public institutions, citizens, and business partners, focusing on innovative and reliable technologies to realize a "Trusted Society," one of Fujitsu's 7 Key Focus Areas under its global business brand Fujitsu Uvance to create a more sustainable world."I am honored to announce the winners and finalists of the 2022 Microsoft Partner of the Year Awards," said Nick Parker, corporate vice president of Global Partner Solutions at Microsoft. "These partners were outstanding among the exceptional pool of nominees and I'm continuously impressed by their innovative use of Microsoft Cloud technologies and the impact for their customers."Microsoft Partner of the Year Awards are announced annually prior to the company's global partner conference, Microsoft Inspire, which will take place on July 19-20 this year.Additional details on the 2022 awards are available on the Microsoft Partner Network blog: bit.ly/3y25ArR. The complete list of categories, winners and finalists can be found at https://partner.microsoft.com/en-us/inspire/awards.About FujitsuFujitsu's purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$32 billion) for the fiscal year ended March 31, 2022 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com. Copyright 2022 JCN Newswire. All rights reserved. (via SEAPRWire)
More
Showa Denko Concludes MOU with SK Inc. to Give Consideration to a Plan to Cooperatively Produce High-Purity Gases for Semiconductors in North America ACN Newswire

Showa Denko Concludes MOU with SK Inc. to Give Consideration to a Plan to Cooperatively Produce High-Purity Gases for Semiconductors in North America

TOKYO, Jun 29, 2022 - (ACN Newswire via SEAPRWire.com) - On June 29, 2022, Showa Denko K.K. (SDK) (TOKYO: 4004) and SK Incorporated concluded a memorandum of understanding (MOU) to give consideration to a plan to start cooperative work to produce high-purity gases, which are used in semiconductor production processes, in North America.While semiconductor markets in various countries continue growing and geopolitical risks are increasing, the US Government has embarked on strengthening domestic semiconductor industry and inviting supply chain of semiconductors into the country. As a result of this movement, large manufacturers of semiconductors are increasing their capital investment in the United States, and the demand for materials for semiconductors in the country is growing. Supply-demand balance of high-purity gases for wiring process (front-end of semiconductor production process) in the US has been tightening. Therefore, many semiconductor manufacturers in the US want to secure stable supply of high-purity gases for semiconductors. On the other hand, SDK's business segment to produce high purity gases for semiconductors has established and continues strengthening high-purity gas supply chain in which the Company producing high-purity gases and filling it into cylinders in its Asian facilities, and transporting those cylinders to the US. Therefore, there are some problems to be solved including increases in transportation costs and potential instability in supply of high-purity gases when there is congestion in global logistics network.To cope with these problems, SDK and SK Materials, which is an in-house independent company of SK Incorporated and produces high-purity gases for semiconductors, will start to give consideration to a plan to cooperatively produce high-purity gases for semiconductors in North America. In the global market for high-purity gases for semiconductors, SDK has the top share of the etching gas*1 market, and SK Materials has the top share of the cleaning gas*2 market and deposition gas*3 market. Thus, the two leading companies in the high-purity gas industry are now aiming to expand their business in the US cooperatively.In 2017, SDK and SK Materials established a joint corporation named SK Showa Denko, Co., Ltd. which produces and sells high-purity gases for semiconductors, and, in the Republic of Korea, they cooperatively produce CH3F, which is used mainly as etching gas for silicon nitride film. Now SK Showa Denko is constructing a new plant to produce HBr in the Republic of Korea, and the new plant is expected to be finished in July, 2022.As a "Co-creative Chemical Company," the Sowa Denko Group has positioned its electronics business including the business to produce and sell high-purity gases for semiconductors as Core-growth Business, and has been focusing on this electronics business, aiming to contribute to sustainable development of the global society. The Showa Denko Group will continue making its electronics business grow by responding rapidly to the growth of semiconductor market and continuing supply of leading-edge products.*1. Etching gas is used in etching process, which is a process to carve fine grooves and holes on the surface of wafers in order to make up electronic circuits, etc.*2. Cleaning gas is used to clean up inside of semiconductor chip production equipment.*3. Deposition gas forms silicon oxide film or silicon nitride film on the surface of wafers.About Showa Denko K.K.Showa Denko K.K. (SDK; TSE:4004, ADR:SHWDY) is a major manufacturer of chemical products serving from heavy industry to computers and electronics. The Petrochemicals Sector provides cracker products such as ethylene and propylene, the Chemicals Sector provides industrial, high-performance and high-purity gases and chemicals for semicon and other industries, the Inorganics Sector provides ceramic products, such as alumina, abrasives, refractory/graphite electrodes and fine carbon products. The Aluminum Sector provides aluminum materials and high-value-added fabricated aluminum, the Electronics Sector provides HD media, compound semiconductors such as ultra high bright LEDs, and rare earth magnetic alloys, and the Advanced Battery Materials Department (ABM) provides lithium-ion battery components. For more information, please visit www.sdk.co.jp/english/.Media contact:Showa Denko K.K., Public Relations Group, Brand Communication Department, Tel: 81-3-5470-3235 Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More